UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~April~~July 4, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-14962

CIRCOR INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

04-3477276

(State or Other Jurisdiction of
Incorporation or Organization)

(I.R.S. Employer
Identification No.)

30 Corporate Drive, Suite 200

Burlington,

01803-4238

(Address of principal executive offices)

(Zip Code)

(781) 270-1200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12 (b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	CIR	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer," “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May 6,~~August 4, 2021, there were ~~20,246,875~~20,252,728 shares of the registrant’s Common Stock, par value $0.01 per share, outstanding.

CIRCOR INTERNATIONAL, INC.

TABLE OF CONTENTS


		Page
PART I.	FINANCIAL INFORMATION	3
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets as of ~~April~~July 4, 2021 and December 31, 2020	3
	Condensed Consolidated Statements of Operations for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020	4
	Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020	5
	Condensed Consolidated Statements of Cash Flows for the~~Three~~ Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020	6
	Condensed Consolidated Statements of Shareholders' Equity for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3336
Item 4.	Controls and Procedures	3437
PART II.	OTHER INFORMATION	3538
Item 1.	Legal Proceedings	3538
~~Item 1A.~~	~~Risk Factors~~	35




Item 6.	Exhibits	3739
Signatures		3840

PART I. FINANCIAL INFORMATION


ITEM 1.			FINANCIAL STATEMENTS

CIRCOR INTERNATIONAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

(UNAUDITED)


		April 4, 2021		December 31, 2020			July 4, 2021		December 31, 2020
ASSETS	ASSETS					ASSETS
CURRENT ASSETS:	CURRENT ASSETS:					CURRENT ASSETS:
Cash and cash equivalents	Cash and cash equivalents	$	75,680	$	76,452	Cash and cash equivalents	$	72,181	$	76,452

Trade accounts receivable, less allowance for doubtful accounts of $8,585 and $9,035 at April 4, 2021 and December 31, 2020, respectively		105,607		102,730
Trade accounts receivable, less allowance for doubtful accounts of $8,596 and $9,035 at July 4, 2021 and December 31, 2020, respectively						Trade accounts receivable, less allowance for doubtful accounts of $8,596 and $9,035 at July 4, 2021 and December 31, 2020, respectively	96,591		102,730
Inventories	Inventories	135,291		129,084		Inventories	136,012		129,084

Prepaid expenses and other current assets	Prepaid expenses and other current assets	103,632		93,226		Prepaid expenses and other current assets	109,683		93,226

Assets held for sale	Assets held for sale	0		5,073		Assets held for sale	0		5,073
Total Current Assets	Total Current Assets	420,210		406,565		Total Current Assets	414,467		406,565
PROPERTY, PLANT AND EQUIPMENT, NET	PROPERTY, PLANT AND EQUIPMENT, NET	163,431		168,763		PROPERTY, PLANT AND EQUIPMENT, NET	160,817		168,763
OTHER ASSETS:	OTHER ASSETS:					OTHER ASSETS:
Goodwill	Goodwill	156,917		158,944		Goodwill	156,785		158,944
Intangibles, net	Intangibles, net	337,864		353,595		Intangibles, net	328,957		353,595
Deferred income taxes	Deferred income taxes	781		779		Deferred income taxes	776		779
Other assets	Other assets	43,999		41,882		Other assets	40,199		41,882
TOTAL ASSETS	TOTAL ASSETS	$	1,123,202	$	1,130,528	TOTAL ASSETS	$	1,102,001	$	1,130,528
LIABILITIES AND SHAREHOLDERS’ EQUITY	LIABILITIES AND SHAREHOLDERS’ EQUITY					LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:	CURRENT LIABILITIES:					CURRENT LIABILITIES:
Accounts payable	Accounts payable	$	67,126	$	61,236	Accounts payable	$	68,224	$	61,236
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	67,059		75,624		Accrued expenses and other current liabilities	72,294		75,624
Accrued compensation and benefits	Accrued compensation and benefits	31,338		28,332		Accrued compensation and benefits	29,721		28,332

Total Current Liabilities	Total Current Liabilities	165,523		165,192		Total Current Liabilities	170,239		165,192
LONG-TERM DEBT	LONG-TERM DEBT	525,573		507,888		LONG-TERM DEBT	512,375		507,888
DEFERRED INCOME TAXES	DEFERRED INCOME TAXES	27,071		28,980		DEFERRED INCOME TAXES	27,562		28,980
PENSION LIABILITY, NET	PENSION LIABILITY, NET	156,746		163,642		PENSION LIABILITY, NET	156,501		163,642
OTHER NON-CURRENT LIABILITIES	OTHER NON-CURRENT LIABILITIES	52,183		58,785		OTHER NON-CURRENT LIABILITIES	52,284		58,785
COMMITMENTS AND CONTINGENCIES (NOTE 11)

SHAREHOLDERS’ EQUITY:	SHAREHOLDERS’ EQUITY:					SHAREHOLDERS’ EQUITY:
Preferred stock, $0.01 par value; 1,000,000 shares authorized; no shares issued and outstanding	Preferred stock, $0.01 par value; 1,000,000 shares authorized; no shares issued and outstanding	0		0		Preferred stock, $0.01 par value; 1,000,000 shares authorized; no shares issued and outstanding	0		0
Common stock, $0.01 par value; 29,000,000 shares authorized; 21,543,496 and 21,373,813 issued at April 4, 2021 and December 31, 2020 respectively		216		214
Common stock, $0.01 par value; 29,000,000 shares authorized; 21,620,528 and 21,373,813 issued at July 4, 2021 and December 31, 2020 respectively						Common stock, $0.01 par value; 29,000,000 shares authorized; 21,620,528 and 21,373,813 issued at July 4, 2021 and December 31, 2020 respectively	216		214
Additional paid-in capital	Additional paid-in capital	451,858		452,728		Additional paid-in capital	452,512		452,728
(Accumulated deficit) retained earnings	(Accumulated deficit) retained earnings	(93,580)		(86,461)		(Accumulated deficit) retained earnings	(109,143)		(86,461)
Common treasury stock, at cost (1,372,488 shares at April 4, 2021 and December 31, 2020)		(74,472)		(74,472)
Common treasury stock, at cost (1,372,488 shares at July 4, 2021 and December 31, 2020)						Common treasury stock, at cost (1,372,488 shares at July 4, 2021 and December 31, 2020)	(74,472)		(74,472)
Accumulated other comprehensive loss, net of tax	Accumulated other comprehensive loss, net of tax	(87,916)		(85,968)		Accumulated other comprehensive loss, net of tax	(86,073)		(85,968)
Total Shareholders’ Equity	Total Shareholders’ Equity	196,106		206,041		Total Shareholders’ Equity	183,040		206,041
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,123,202	$	1,130,528	TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,102,001	$	1,130,528

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRCOR INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(UNAUDITED)


		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Net revenues	Net revenues	$	180,655	$	192,213		Net revenues	$	190,346	$	186,066	$	371,001	$	378,279
Cost of revenues	Cost of revenues	124,574		132,170			Cost of revenues	130,460		127,105		255,034		259,275
Gross profit	Gross profit	56,081		60,043			Gross profit	59,886		58,961		115,967		119,004
Selling, general and administrative expenses	Selling, general and administrative expenses	56,504		59,558			Selling, general and administrative expenses	58,023		54,738		114,526		114,296
Goodwill impairment charge		0		116,182
Impairment charges							Impairment charges	0		0		0		116,182
Special and restructuring charges (recoveries), net	Special and restructuring charges (recoveries), net	(809)		(42,292)			Special and restructuring charges (recoveries), net	6,803		5,607		5,995		(36,685)
Operating income (loss)	Operating income (loss)	386		(73,405)			Operating income (loss)	(4,940)		(1,384)		(4,554)		(74,789)
Other expense (income):	Other expense (income):						Other expense (income):
Interest expense, net	Interest expense, net	8,369		9,011			Interest expense, net	7,957		8,486		16,327		17,497
Other expense (income), net	Other expense (income), net	(1,503)		(2,680)			Other expense (income), net	(1,173)		2,144		(2,676)		(536)
Total other expense, net	Total other expense, net	6,866		6,331			Total other expense, net	6,784		10,630		13,651		16,961
(Loss) income from continuing operations before income taxes		(6,480)		(79,736)
Income (loss) from continuing operations before income taxes							Income (loss) from continuing operations before income taxes	(11,724)		(12,014)		(18,205)		(91,750)
Provision for (benefit from) income taxes	Provision for (benefit from) income taxes	400		8,374			Provision for (benefit from) income taxes	2,961		(21,769)		3,360		(13,395)
(Loss) income from continuing operations, net of tax		(6,880)		(88,110)
Income (loss) from continuing operations, net of tax							Income (loss) from continuing operations, net of tax	(14,685)		9,755		(21,565)		(78,355)
Income (loss) from discontinued operations, net of tax	Income (loss) from discontinued operations, net of tax	(239)		9,162			Income (loss) from discontinued operations, net of tax	(878)		(43,847)		(1,117)		(34,685)
Net loss	Net loss	$	(7,119)	$	(78,948)		Net loss	$	(15,563)	$	(34,092)	$	(22,682)	$	(113,040)

Basic income (loss) per common share:	Basic income (loss) per common share:						Basic income (loss) per common share:
Basic from continuing operations	Basic from continuing operations	$	(0.34)	$	(4.42)		Basic from continuing operations	$	(0.73)	$	0.49	$	(1.07)	$	(3.93)
Basic from discontinued operations	Basic from discontinued operations	$	(0.01)	$	0.46		Basic from discontinued operations	$	(0.04)	$	(2.19)	$	(0.06)	$	(1.74)
Net loss	Net loss	$	(0.35)	$	(3.96)		Net loss	$	(0.77)	$	(1.71)	$	(1.13)	$	(5.66)

Diluted income (loss) per common share:	Diluted income (loss) per common share:						Diluted income (loss) per common share:
Diluted from continuing operations	Diluted from continuing operations	$	(0.34)	$	(4.42)		Diluted from continuing operations	$	(0.73)	$	0.48	$	(1.07)	$	(3.93)
Diluted from discontinued operations	Diluted from discontinued operations	$	(0.01)	$	0.46		Diluted from discontinued operations	$	(0.04)	$	(2.16)	$	(0.06)	$	(1.74)
Net loss	Net loss	$	(0.35)	$	(3.96)		Net loss	$	(0.77)	$	(1.68)	$	(1.13)	$	(5.66)

Weighted average number of common shares outstanding:	Weighted average number of common shares outstanding:						Weighted average number of common shares outstanding:
Basic	Basic	20,054		19,935			Basic	20,230		19,987		20,143		19,962
Diluted	Diluted	20,054		19,935			Diluted	20,230		20,286		20,143		19,962

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRCOR INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(in thousands)

(UNAUDITED)


		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Net loss	Net loss	$	(7,119)	$	(78,948)		Net loss	$	(15,563)	$	(34,092)	$	(22,682)	$	(113,040)
Other comprehensive income (loss), net of tax:	Other comprehensive income (loss), net of tax:						Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	Foreign currency translation adjustments	(3,594)		(20,325)			Foreign currency translation adjustments	232		14,090		(3,364)		(6,235)
Interest rate swap adjustments (1)	Interest rate swap adjustments (1)	1,586		(2,320)			Interest rate swap adjustments (1)	1,562		755		3,148		(1,565)
Pension adjustment	Pension adjustment	60		39			Pension adjustment	49		43		111		82

Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	(1,948)		(22,606)			Other comprehensive income (loss), net of tax	1,843		14,888		(105)		(7,718)
COMPREHENSIVE LOSS	COMPREHENSIVE LOSS	$	(9,067)	$	(101,554)		COMPREHENSIVE LOSS	$	(13,720)	$	(19,204)	$	(22,787)	$	(120,758)

(1) Net of an income tax effect of $0.0 million and $0.7 million for the three months ended April 4, 2021 and March 29, 2020, respectively.
(1) Net of an income tax effect of $0.0 million and $0.2 million for the three months ended July 4, 2021 and June 28, 2020, respectively, and $0.0 million and $(0.5) million for the six months ended July 4, 2021 and June 28, 2020 respectively.							(1) Net of an income tax effect of $0.0 million and $0.2 million for the three months ended July 4, 2021 and June 28, 2020, respectively, and $0.0 million and $(0.5) million for the six months ended July 4, 2021 and June 28, 2020 respectively.

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRCOR INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(UNAUDITED)

Three Months Ended
OPERATING ACTIVITIES April 4, 2021 March 29, 2020
Net loss $ (7,119) $ (78,948)
Income (loss) from discontinued operations, net of income taxes (239) 9,162
Loss from continuing operations (6,880) (88,110)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation 6,509 5,121
Amortization 10,696 10,611
Provision for bad debt expense (254) 5,802
Write down of inventory 129 343
Compensation expense for share-based plans 1,402 608
Amortization of debt issuance costs 995 4,513
Deferred tax provision 823 0
Goodwill impairment charge 0 116,182
(Gain) Loss on sale of businesses (1,947) (54,356)
Changes in operating assets and liabilities, net of effects of disposition:
Trade accounts receivable (3,793) (1,550)
Inventories (8,055) (13,365)
Prepaid expenses and other assets (15,332) (5,507)
Accounts payable, accrued expenses and other liabilities (1,360) 1,081
Net cash used in continuing operating activities (17,067) (18,627)
Net cash used in discontinued operating activities (636) (5,320)
Net cash used in operating activities (17,703) (23,947)
INVESTING ACTIVITIES
Additions to property, plant and equipment (3,394) (3,412)
Proceeds from the sale of property, plant and equipment 2 0
Proceeds from the sale of business 7,193 169,773
Proceeds from beneficial interest of factored receivables 812 599
Net cash provided by continuing investing activities 4,613 166,960
Net cash provided by discontinued investing activities 0 68
Net cash provided by investing activities 4,613 167,028
FINANCING ACTIVITIES
Proceeds from long-term debt 63,500 129,325
Payments of long-term debt (46,500) (180,891)
Proceeds from the exercise of stock options 151 118
Withholding tax payments on net share settlements of equity awards (3,274) 0
Net cash provided by (used in) financing activities 13,877 (51,448)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,545) (5,389)
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH (758) 86,244
Cash, cash equivalents, and restricted cash at beginning of period 77,696 85,727
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD $ 76,938 $ 171,971
Non-cash investing activities:
Purchases of property and equipment included in accounts payable and accrued expenses $ 929 $ 870


	Six Months Ended
OPERATING ACTIVITIES	July 4, 2021		June 28, 2020
Net loss	$	(22,682)	$	(113,040)
Income (loss) from discontinued operations, net of income taxes	(1,117)		(34,685)
Loss from continuing operations	(21,565)		(78,355)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	11,970		10,079
Amortization	21,353		21,492
Change in provision for bad debt expense	(350)		7,768
Write down of inventory	961		352
Compensation expense for share-based plans	2,903		2,290
Amortization of debt issuance costs	2,005		5,488
Deferred tax provision	823		0

Goodwill Impairment	0		116,182
(Gain) Loss on sale of businesses	1,031		(54,253)
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Trade accounts receivable	6,345		768
Inventories	(14,038)		(12,370)
Prepaid expenses and other assets	(17,792)		(25,264)
Accounts payable, accrued expenses and other liabilities	214		(31,475)
Net cash used in continuing operating activities	(6,140)		(37,298)
Net cash used in discontinued operating activities	(579)		(11,532)
Net cash used in operating activities	(6,719)		(48,830)
INVESTING ACTIVITIES
Additions to property, plant and equipment	(6,038)		(6,815)
Proceeds from the sale of property, plant and equipment	2		(142)
Proceeds from the sale of business	9,993		169,375
Proceeds from beneficial interest of factored receivables	998		1,339

Net cash provided by continuing investing activities	4,955		163,757
Net cash provided by (used in) discontinued investing activities	0		(10,071)
Net cash provided by investing activities	4,955		153,686
FINANCING ACTIVITIES
Proceeds from long-term debt	103,350		129,325
Payments of long-term debt	(100,250)		(191,141)
Proceeds from the exercise of stock options	151		118
Withholding tax payments on net share settlements of equity awards	(4,119)		0





Net cash provided by (used in) financing activities	(868)		(61,698)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,627)		(2,421)
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(4,259)		40,737
Cash, cash equivalents, and restricted cash at beginning of period	77,696		85,727
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	$	73,437	$	126,464



Non-cash investing activities:
Purchases of property and equipment included in accounts payable and accrued expenses	$	647	$	577

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRCOR INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

FOR THE THREE AND SIX MONTHS ENDED ~~APRIL~~JULY 4, 2021 AND ~~MARCH 29,~~JUNE 28, 2020

(in thousands)

(UNAUDITED)


		Common Stock			Additional Paid-in Capital		Retained Earnings (Accum-ulated Deficit)		Accumulated Other Comprehensive Loss		Treasury Stock		Total Shareholders’ Equity			Common Stock			Additional Paid-in Capital		Retained Earnings (Accumulated deficit)		Accumulated Other Comprehensive Loss		Treasury Stock		Total Shareholders’ Equity
		Shares	Amount													Shares	Amount
Balance as of December 31, 2020	Balance as of December 31, 2020	20,001	$	214	$	452,728	$	(86,461)	$	(85,968)	$	(74,472)	$	206,041	Balance as of December 31, 2020	20,001	$	214	$	452,728	$	(86,461)	$	(85,968)	$	(74,472)	$	206,041
Net loss															Net loss	—	—		—		(7,119)		—		—		(7,119)
Other comprehensive loss, net of tax															Other comprehensive loss, net of tax	—	—		—		—		(1,948)		—		(1,948)
Conversion of restricted stock units and tax withholding on net share settlements															Conversion of restricted stock units and tax withholding on net share settlements	165	2		(2,423)		—		—		—		(2,421)
Stock options exercised															Stock options exercised	5	—		151		—		—		—		151
Share-based plan compensation															Share-based plan compensation	—	—		1,402		—		—		—		1,402
Balance as of April 4, 2021															Balance as of April 4, 2021	20,171	$	216	$	451,858	$	(93,580)	$	(87,916)	$	(74,472)	$	196,106

Net loss	Net loss	—	—		—		(7,119)		—		—		(7,119)		Net loss	—	—		—		(15,563)		—				(15,563)
Other comprehensive income, net of tax	Other comprehensive income, net of tax	—	—		—		—		(1,948)		—		(1,948)		Other comprehensive income, net of tax						—		1,843				1,843

Conversion of restricted stock units and tax withholding on net share settlements	Conversion of restricted stock units and tax withholding on net share settlements	165	2		(2,423)		—		—		—		(2,421)		Conversion of restricted stock units and tax withholding on net share settlements	59	—		(847)		0		—		—		(847)
Stock options exercised	Stock options exercised	5	—		151		—		—		—		151		Stock options exercised	18	0		—		—		—		—		0
Share-based plan compensation	Share-based plan compensation	—	—		1,402		—		—		—		1,402		Share-based plan compensation	—	—		1,501		—		—		—		1,501
Balance as of July 4, 2021															Balance as of July 4, 2021	20,248	216		452,512		(109,143)		(86,073)		(74,472)		183,040

Balance as of April 4, 2021		20,171	$	216	$	451,858	$	(93,580)	$	(87,916)	$	(74,472)	$	196,106

Balance as of December 31, 2019		19,912	$	213	$	446,657	$	99,280	$	(80,267)	$	(74,472)	$	391,411
Net loss		—	—		—		(78,948)		—		—		(78,948)
Other comprehensive loss, net of tax		—	—		—		—		(22,606)		—		(22,606)
Cumulative effect adjustment related to the adoption of current expected credit loss standard (ASC 326)		—	—		—		(222)		—		—		(222)
Conversion of restricted stock units and tax withholding on net share settlements		41	—		420		$	—	$	—	$	—	$	420
Stock options exercised		3	—		117		—		—		—		117
Share-based plan compensation		—	—		673		—		—		—		673
Balance as of March 29, 2020		19,956	$	213	$	447,867	$	20,110	$	(102,873)	$	(74,472)	$	290,845



	Common Stock			Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Loss		Treasury Stock		Total Shareholders’ Equity
	Shares	Amount
Balance as of December 31, 2019	19,912	$	213	$	446,657	$	99,280	$	(80,267)	$	(74,472)	$	391,411
Net loss	—	—		—		(78,948)		—		—		(78,948)
Other comprehensive loss, net of tax	—	—		—		—		(22,606)		—		(22,606)
Cumulative effect adjustment related to adoption of current expected credit loss standard (ASC 326)	—	—		—		(222)		—		—		(222)
Conversion of restricted stock units	41	0		420		—		—		—		420
Stock options exercised	3	—		117		—		—		—		117
Share-based plan compensation	—	—		673		—		—		—		673
Balance as of March 29, 2020	19,956	$	213	$	447,867	$	20,110	$	(102,873)	$	(74,472)	$	290,845

Net loss	—	—		—		(34,092)		—		—		(34,092)
Other comprehensive income, net of tax	—	—		—		—		14,888		—		14,888
Conversion of restricted stock units	38	1		(134)		—		—		—		(133)
Share-based plan compensation	—	—		1,843		—		—		—		1,843
Balance as of June 28, 2020	19,994	$	214	$	449,576	$	(13,982)	$	(87,985)	$	(74,472)	$	273,351

CIRCOR INTERNATIONAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(1) Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of CIRCOR International, Inc. ("CIRCOR", or the "Company"~~, "us", "we" or "our"~~) have been prepared according to the rules and regulations of the United States ("U.S.") Securities and Exchange Commission (“SEC”) for interim reporting, along with accounting principles generally accepted in the ~~U.S~~U.S. ("GAAP"). In the opinion of management, the unaudited, condensed consolidated financial statements reflect all adjustments (consisting only of normal and recurring items) necessary for a fair presentation of the Company’s results of operations, financial position and cash flows for the periods presented. The Company prepares its interim financial information using the same accounting principles it uses for its annual audited consolidated financial statements. Certain information and note disclosures normally included in the annual audited consolidated financial statements have been condensed or omitted in accordance with SEC rules. The Company believes that the disclosures made in its condensed consolidated financial statements and the accompanying notes are adequate to make the information presented not misleading.

The condensed consolidated balance sheet as of December 31, 2020 was derived from CIRCOR's audited consolidated financial statements as of that date but does not include all of the information and notes required for annual financial statements. The Company recommends that the financial statements included in its Quarterly Report on Form 10-Q be read in conjunction with the consolidated financial statements and notes included in its Annual Report on Form 10-K for the year ended December 31, 2020.

CIRCOR operates and reports financial information using a fiscal year ending December 31. The data periods contained within its Quarterly Reports on Form 10-Q reflect the results of operations for the 13-week, 26-week and 39-week periods which generally end on the Sunday nearest to the calendar quarter-end date. Operating results for the three and six months ended ~~April~~July 4, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or any future ~~quarter.~~period.

Unless otherwise indicated, all financial information and statistical data included in these notes to the Company's condensed consolidated financial statements relate to its continuing operations, with dollar amounts expressed in thousands (except share and per-share data).

COVID-19

In March 2020, the World Health Organization declared the outbreak of COVID-19, which continues to spread throughout the U.S. and the world, as a pandemic. The pandemic is having an impact on the global economy, resulting in rapidly changing market and economic conditions. As of March 29, 2020, the Company experienced a significant decline in its market capitalization below its consolidated book value. As a result, management concluded that there was a goodwill and an intangible asset impairment triggering event for the Company in the first quarter of 2020. Through its impairment analysis, the Company determined that goodwill in its Industrial segment was impaired and recognized a $116.2 million impairment charge. See Note 7, Goodwill and Intangibles, net, for additional information on the goodwill impairment.

The effects of the COVID-19 pandemic continue to negatively impact the Company's results of operations, cash flows and financial position. The Company’s condensed consolidated financial statements presented herein reflect management's estimates and assumptions regarding the effects of COVID-19 as of the date of the condensed consolidated financial statements.

(2) Summary of Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and six months ended ~~April~~July 4, 2021 are consistent with those discussed in Note 2 to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, except as updated below with respect to newly adopted accounting standards.

The preparation of these financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying disclosures. Some of the more significant estimates, which are impacted by management's estimates and assumptions regarding the effects of COVID-19, relate to recoverability of goodwill and indefinite-lived trade names, estimated total costs for ongoing long-term

revenue contracts where transfer of control occurs over time, inventory valuation, share-based compensation, amortization and

impairment of long-lived assets, income taxes (including valuation allowance), fair value of disposal group, pension ~~benefits~~benefit obligations, acquisition accounting, penalty accruals for late shipments, asset valuations, and product warranties. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ materially from those estimates.

New Accounting Standards - Adopted

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. In January 2021, the FASB issued ASU 2021-01 which clarified the scope of Topic 848. Topic 848 contains optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships, and other areas or transactions that are impacted by reference rate reform (i.e., by the transition of LIBOR and other interbank offered rates to alternative reference interest rates). The new standard was effective upon issuance and generally can be applied to contract modifications through December 31, 2022. The Company adopted this standard as of January 1, 2021, and intends to apply the provisions of this standard to contract modifications if and when applicable. During the ~~three months~~interim period ended ~~April~~July 4, 2021, the adoption of the standard did not have a material impact on the Company's condensed consolidated financial statements.

On January 1, 2020, the Company adopted FASB ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. The Company adopted the standard using a modified retrospective approach through a cumulative-effect adjustment to retained earnings. It recognized the cumulative effect of adopting the new credit loss standard as an adjustment to the opening balance of retained earnings as of January 1, 2020. The adoption of the standard did not have a material impact on the Company's condensed consolidated financial statements.

(3) Discontinued Operations

Discontinued Operations

During 2020, the Company’s wholly-owned subsidiary, CIRCOR Energy Products LLC ("CEP"), completed the disposition of its DV business. The transaction is subject to an earn out of 50% of net profit (only if positive) from closing through December 31, 2022. As part of the transaction, CEP retained certain ~~supplier~~ liabilities and responsibility for closing CEP's Mexico manufacturing facility. During the three and six months ended July 4, 2021, the Company incurred net charges for the settlement of certain retained liabilities.

The following table presents the summarized components of income (loss) from discontinued operations of the DV business for the three and six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 (in thousands):


		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Net revenues	Net revenues	$	0	$	6,237		Net revenues	$	0	$	3,818	$	0	$	10,055
Cost of revenues	Cost of revenues	0		11,358			Cost of revenues	0		15,040		0		26,398
Gross (loss) profit		0		(5,121)
Gross profit (loss)							Gross profit (loss)	0		(11,222)		0		(16,343)
Selling, general and administrative expenses	Selling, general and administrative expenses	0		3,139			Selling, general and administrative expenses	(84)		5,935		(84)		9,074

Special and restructuring charges (recoveries), net	Special and restructuring charges (recoveries), net	(152)		(1,328)			Special and restructuring charges (recoveries), net	200		20,454		48		19,126
Operating income (loss)	Operating income (loss)	152		(6,932)			Operating income (loss)	(116)		(37,611)		36		(44,543)
Other (income) expense:	Other (income) expense:						Other (income) expense:
Interest (income), net	Interest (income), net	0		(7)			Interest (income), net	0		(7)		0		(14)
Other (income) expense, net	Other (income) expense, net	118		5,410			Other (income) expense, net	780		(5,191)		898		219
Total other (income) expense, net	Total other (income) expense, net	118		5,403			Total other (income) expense, net	780		(5,198)		898		205
Income (loss) from discontinued operations, before income taxes	Income (loss) from discontinued operations, before income taxes	34		(12,335)			Income (loss) from discontinued operations, before income taxes	(896)		(32,413)		(862)		(44,748)
Provision for (benefit from) income tax	Provision for (benefit from) income tax	273		(21,497)			Provision for (benefit from) income tax	(18)		11,434		255		(10,063)
Income (loss) from discontinued operations, net of tax	Income (loss) from discontinued operations, net of tax	$	(239)	$	9,162		Income (loss) from discontinued operations, net of tax	$	(878)	$	(43,847)	$	(1,117)	$	(34,685)

~~Assets Held for Sale~~

The Company completed the sale of its Cryogenic Valves business ("Cryo") during the quarter ended April 4, 2021. See Note 5, Special and Restructuring Charges (Recoveries), net for additional information on the Cryo business divestiture. As of December 31, 2020, the Cryo business satisfied the held for sale classification criteria and was reported as "held for sale" within the current assets section of our condensed consolidated balance sheet.

~~The following table presents the balance sheet information for assets held for sale as of December 31, 2020 (in thousands~~):


	~~December 31, 2020~~
	~~Cryo~~

~~Inventories~~	$	~~2,963~~
~~Prepaid expenses and other current assets~~	48
~~Property, plant, and equipment, net~~	~~162~~
~~Goodwill~~	~~1,900~~




~~Total assets held for sale~~	$	~~5,073~~

(4) Revenue Recognition

The Company's revenue is derived from a variety of contracts. A significant portion of revenues are from contracts associated with the design, development, manufacture or modification of highly engineered, complex and severe environment products with customers who are either in or service the aerospace, defense and industrial markets. Contracts within the defense markets are primarily with U.S. military customers. These contracts typically are subject to the Federal Acquisition Regulations ("FAR"). The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. Contracts may be modified to account for changes in contract specifications and requirements.

For revenue that is recognized from products and services transferred to customers over-time, the Company uses an input measure (e.g., costs incurred to date relative to total estimated costs at completion, known as the “cost-to-cost” method) to measure progress. The Company uses the cost-to-cost measure of progress because it best depicts the transfer of control to the customer which occurs as it incurs costs on its contracts. Under the cost-to-cost measure of progress, revenue is recognized proportionally as costs are incurred. Contract costs include labor, materials and subcontractors’ costs, other direct costs and an allocation of overhead, as appropriate.

As of ~~April~~July 4, 2021, the Company had ~~$208.7~~$220.1 million of transaction price related to remaining performance obligations. The Company expects to recognize approximately ~~62%~~45% of its remaining performance obligations as revenue during the remainder of 2021, ~~25%~~37% in 2022, and the remaining ~~13%~~18% in 2023 and thereafter.

In order to determine revenue recognized during the period from contract liabilities at the beginning of the period, the Company first allocates revenue to the individual contract liabilities balances outstanding at the beginning of the period until the revenue exceeds that balance. If additional advances are received on those contracts in subsequent periods, it assumes all revenue recognized in the reporting period first applies to the beginning contract liabilities as opposed to a portion applying to the new advances for the period. Revenue recognized during the ~~three~~six months ended ~~April~~July 4, 2021 that was included in contract liabilities as of the beginning of the period amounted to ~~$14.3~~$16.2 million.

Disaggregation of Revenue. The Company determined that disaggregating revenue into these categories meets the disclosure objective in Topic 606 which is to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The following tables present ~~our~~ revenue disaggregated by major product line and geographical market (in thousands):


			Three Months Ended				Three Months Ended					Six Months Ended
			April 4, 2021		March 29, 2020					July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020

Aerospace & Defense Segment	Aerospace & Defense Segment							Aerospace & Defense Segment
		Commercial Aerospace & Other	$	19,800	$	26,320			Commercial Aerospace & Other	$	26,300	$	25,195	$	46,101	$	51,515
		Defense	40,201		39,173				Defense	34,461		37,046		74,661		76,219
		Total	60,001		65,493				Total	60,761		62,241		120,762		127,734
Industrial Segment	Industrial Segment							Industrial Segment
		Valves	45,763		54,190				Valves	47,018		49,452		92,781		103,643
		Pumps	74,891		72,530				Pumps	82,567		74,373		157,458		146,902
		Total	120,654		126,720				Total	129,585		123,825		250,239		250,545
Net Revenue	Net Revenue		$	180,655	$	192,213		Net Revenue		$	190,346	$	186,066	$	371,001	$	378,279

Three Months Ended
April 4, 2021 March 29, 2020
Aerospace & Defense Segment
EMEA $ 15,214 $ 14,806
North America 41,645 45,988
Other 3,142 4,699
Total 60,001 65,493
Industrial Segment
EMEA 58,003 57,006
North America 31,788 43,922
Other 30,863 25,792
Total 120,654 126,720
Net Revenue $ 180,655 $ 192,213


		Three Months Ended				Six Months Ended
		July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020


Aerospace & Defense Segment
	EMEA	$	13,634	$	14,254	$	28,849	$	29,061
	North America	43,470		44,707		85,115		90,695
	Other	3,657		3,280		6,798		7,978
	Total	60,761		62,241		120,762		127,734
Industrial Segment
	EMEA	61,606		52,420		119,609		109,426
	North America	39,037		43,922		70,825		87,844
	Other	28,942		27,483		59,805		53,275
	Total	129,585		123,825		250,239		250,545

Net Revenue		$	190,346	$	186,066	$	371,001	$	378,279

Contract Balances. The Company’s contract assets and contract liabilities balances as of ~~April~~July 4, 2021 and December 31, 2020 are as follows (in thousands):


		April 4, 2021		December 31, 2020		Increase/(Decrease)			July 4, 2021		December 31, 2020		Increase/(Decrease)

Contract assets:	Contract assets:							Contract assets:
Recorded within prepaid expenses and other current assets	Recorded within prepaid expenses and other current assets	$	68,155	$	67,352	$	803	Recorded within prepaid expenses and other current assets	$	75,680	$	67,352	$	8,328
Recorded within other non-current assets	Recorded within other non-current assets	13,684		10,824		2,860		Recorded within other non-current assets	9,248		10,824		(1,576)
		$	81,839	$	78,176	$	3,663		$	84,928	$	78,176	$	6,752

Contract liabilities:	Contract liabilities:							Contract liabilities:
Recorded within accrued expenses and other current liabilities	Recorded within accrued expenses and other current liabilities	$	19,356	$	23,585	$	(4,229)	Recorded within accrued expenses and other current liabilities	$	17,338	$	23,585	$	(6,247)
Recorded within other non-current liabilities	Recorded within other non-current liabilities	7,998		9,412		(1,414)		Recorded within other non-current liabilities	7,959		9,412		(1,453)
		$	27,354	$	32,997	$	(5,643)		$	25,297	$	32,997	$	(7,700)

Contract assets increased by ~~$3.7~~$6.8 million during the ~~three~~six months ~~period~~ ended ~~April~~July 4, 2021, primarily due to unbilled revenue recognized during the period for over-time revenue contracts within ~~our~~the Defense business partially offset by net transfers from contract assets to receivables within ~~our~~the Refinery Valves business.

Contract liabilities decreased by ~~$5.6~~$7.7 million during the ~~three~~six months ~~period~~ ended ~~April~~July 4, 2021, primarily due to recognition of revenue against customer advances within ~~our~~the Defense business in excess of advances received during the ~~period.~~period partially offset by customer advances received in excess of revenue recognized in the Industrial Pumps and Valves businesses.

Allowance for Credit Losses

The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses or doubtful accounts based upon expected losses, its historical experience, expectation of changes in risk of loss and any specific customer collection issues that it has identified. During the ~~three~~six months ~~period~~ ended ~~April~~July 4, 2021, there were no material changes in the allowance for credit losses including additional allowances, write-offs or recoveries. During the ~~three~~six months ~~period~~ ended ~~March 29,~~June 28, 2020, the Company recognized a $5.9 million charge for allowance against a customer ~~receivable, other~~receivable. Other than that there were no other material changes including additional allowances, write-offs or recoveries.

(5) Special and Restructuring Charges (Recoveries), net

Special and restructuring charges (recoveries), net

Special and restructuring charges (recoveries), net consist of restructuring costs (including costs to exit a product line or program) as well as certain special charges (recoveries) such as significant litigation settlements and other transactions (charges or recoveries) that are described below. All items described below are recorded in Special and restructuring charges (recoveries), net on ~~our~~the condensed consolidated statements of operations. Certain other special and restructuring charges (recoveries) such as inventory related items may be recorded in cost of revenues given the nature of the item.

The table below summarizes the amounts recorded within the special and restructuring charges (recoveries), net line item on the condensed consolidated statements of operations for the three and six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 (in thousands):


		Special & restructuring charges (recoveries), net						Special & restructuring charges (recoveries), net
		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Special charges (recoveries), net	Special charges (recoveries), net	$	(2,869)	$	(45,175)		Special charges (recoveries), net	$	4,522	$	5,019	$	1,654	$	(40,156)
Restructuring charges, net	Restructuring charges, net	2,060		2,883			Restructuring charges, net	2,281		588		4,341		3,471
Total special and restructuring charges (recoveries), net	Total special and restructuring charges (recoveries), net	$	(809)	$	(42,292)		Total special and restructuring charges (recoveries), net	$	6,803	$	5,607	$	5,995	$	(36,685)

Special charges (recoveries), net

The table below details the special charges (recoveries), net recognized for the three and six months ended ~~April~~July 4, 2021 (in thousands):


		Special charges (recoveries), net											Special charges (recoveries), net
		Three Months Ended April 4, 2021											Three Months Ended July 4, 2021
			Aerospace & Defense		Industrial			Corporate		Total			Aerospace & Defense		Industrial		Corporate		Total
Cryo divestiture			$	—	$	(1,947)		$	0	$	(1,947)

Heater & Control Valve divestiture												Heater & Control Valve divestiture	$	0	$	2,978	$	0	$	2,978

Other special charges (recoveries), net	Other special charges (recoveries), net		15		(629)			(308)		(922)		Other special charges (recoveries), net	19		1,248		277		1,544
Total special charges (recoveries), net	Total special charges (recoveries), net		$	15	$	(2,576)		$	(308)	$	(2,869)	Total special charges (recoveries), net	$	19	$	4,226	$	277	$	4,522

							Special charges (recoveries), net
							Six Months Ended July 4, 2021
													Aerospace & Defense		Industrial		Corporate		Total

Cryo divestiture												Cryo divestiture	$	0	$	(1,947)	$	0	$	(1,947)
Heater & Control Valve divestiture												Heater & Control Valve divestiture	0		2,978		0		2,978
Other special charges (recoveries), net												Other special charges (recoveries), net	35		619		(31)		623
Total special charges (recoveries), net												Total special charges (recoveries), net	$	35	$	1,650	$	(31)	$	1,654

Heater & Control Valve divestiture: During the three and six months ended July 4, 2021, the Company received cash proceeds of $2.8 million and recognized a pre-tax loss of $3.0 million on the sale of the Heater & Control Valve businesses.

Cryo divestiture: During the ~~three~~six months ended ~~April~~July 4, 2021, the Company recognized a net special recovery of $1.9 million from the sale of the Cryo business. The Company received cash proceeds of $7.2 million and recognized a pre-tax gain on sale of $1.9 million.

Other special charges (recoveries), net: The Company recognized special ~~recoveries~~charges of $1.5 million and $0.6 million for the three and six months ended ~~April~~July 4, 2021, ~~with recoveries partially offset by charges from initiatives to streamline operations and reduce costs~~respectively. Included in the charge recognized during the three months ended July 4, 2021 within the Industrial ~~segment.~~segment is $0.9 million pertaining to a contingency indemnification to the buyer of a previously divested business. The Company also recognized ~~recoveries~~charges of $0.3 million in ~~Corporate.~~Corporate associated with streamlining operations and reducing costs during the three months ended July 4, 2021.

The table below details the special charges (recoveries), net recognized for the three and six months ended ~~March 29,~~June 28, 2020 (in thousands):


		Special charges (recoveries), net											Special charges (recoveries), net
		Three Months Ended March 29, 2020											Three Months Ended June 28, 2020
			Aerospace & Defense			Industrial		Corporate		Total			Aerospace & Defense		Industrial		Corporate		Total
I&S divestiture	I&S divestiture		$	—		$	(53,202)	$	0	$	(53,202)	I&S divestiture	$	—	$	0	$	(306)	$	(306)
Professional fees to review and respond to an unsolicited tender offer to acquire the Company			—			—		2,355		2,355
Amortization of debt issuance fee			—			—		3,541		3,541
Professional fees												Professional fees	—		0		4,570		4,570
Other special charges	Other special charges		—			101		2,030		2,131		Other special charges	—		0		755		755
Total special charges (recoveries), net	Total special charges (recoveries), net		$	—		$	(53,101)	$	7,926	$	(45,175)	Total special charges (recoveries), net	$	—	$	0	$	5,019	$	5,019

					Special charges (recoveries), net
					Six Months Ended June 28, 2020
													Aerospace & Defense		Industrial		Corporate		Total

I&S divestiture												I&S divestiture	$	—	$	(53,202)	$	(306)	$	(53,508)
Professional fees												Professional fees	—		0		6,925		6,925
Amortization of debt issuance fee												Amortization of debt issuance fee	—		0		3,541		3,541
Other special charges												Other special charges	—		101		2,785		2,886
Total special charges (recoveries), net												Total special charges (recoveries), net	$	—	$	(53,101)	$	12,945	$	(40,156)

I&S Divestiture: In 2020, the Company recorded net special recoveries of ~~$53.2~~$(0.3) million and $(53.5) million for the three and six months ended ~~March 29,~~June 28, 2020, respectively, attributed to the sale of the I&S business in January 2020. During the quarter ended March 29, 2020, the Company received net cash proceeds of $169.8 million and recognized a pre-tax gain on sale of $54.6 million. The Industrial segment incurred $1.4 million of operating expenses associated with the I&S business for the three months ended March 29, 2020, which are presented net within the I&S divestiture line.

Professional fees: The Company incurred special charges of ~~$2.4~~$4.6 million and $6.9 million for the three and six months ended ~~March 29,~~June 28, 2020 respectively, associated with the review and response to an unsolicited tender offer to acquire the Company.

Amortization of debt issuance fee: The Company incurred special charges of $3.5 million for the three and six months ended ~~March 29,~~June 28, 2020 respectively, for accelerated amortization of capitalized debt issuance costs in connection with the accounting for the paydown and refinancing of its term loan during the first quarter of 2020. ~~See Note 9, Financing Arrangements, for additional information on our debt repricing.~~

Other ~~cost savings initiatives:~~special charges: The Company incurred special charges of ~~$2.1~~$0.8 million and $2.9 million for the three and six months ended ~~March 29,~~June 28, 2020 , respectively, associated with ~~professional fees for~~ projects to streamline operations and reduce ~~costs of $1.2 million, costs of a cyber incident of $0.7 million and charges related to previous business sales of $0.2 million.~~costs.

Restructuring charges, net

The tables below detail the charges associated with restructuring actions recorded for the three and six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020. Accruals associated with the restructuring actions are recorded within Accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):


		Restructuring charges, net									Restructuring charges, net
		As of and for the Three Months Ended April 4, 2021									As of and for the Three Months Ended July 4, 2021
		Aerospace & Defense		Industrial		Corporate		Total			Aerospace & Defense		Industrial		Corporate		Total
Facility related charges	Facility related charges	$	8	$	(75)	$	0	$	(67)	Facility related charges	$	16	$	427	$	0	$	443
Employee related charges		833		976		318		2,127
Employee related charges, net										Employee related charges, net	337		1,448		53		1,838
Total restructuring charges, net	Total restructuring charges, net	$	841	$	901	$	318	$	2,060	Total restructuring charges, net	$	353	$	1,875	$	53	$	2,281

Accrued restructuring charges as of December 31, 2020								$	1,512
Total charges, net (shown above)								2,060
Charges paid / settled, net								(1,777)
Accrued restructuring charges as of April 4, 2021								$	1,795

											Restructuring charges, net
											As of and for the Six Months Ended July 4, 2021
											Aerospace & Defense		Industrial		Corporate		Total
Facility related expenses										Facility related expenses	$	24	$	352	$	0	$	376
Employee related expenses, net										Employee related expenses, net	1,170		2,424		371		3,965
Total restructuring charges, net										Total restructuring charges, net	$	1,194	$	2,776	$	371	$	4,341

Accrued restructuring charges as of December 31, 2020										Accrued restructuring charges as of December 31, 2020							$	1,512
Total charges, net (shown above)										Total charges, net (shown above)							4,341
Charges paid / settled, net										Charges paid / settled, net							(2,453)
Accrued restructuring charges as of July 4, 2021										Accrued restructuring charges as of July 4, 2021							$	3,400

The Company expects to make payment or settle the majority of the restructuring charges accrued as of ~~April~~July 4, 2021 during the next ~~nine~~six months.


		Restructuring charges, net									Restructuring charges, net
		As of and for the Three Months Ended March 29, 2020									As of and for the Three Months Ended June 28, 2020
		Aerospace & Defense		Industrial		Corporate		Total			Aerospace & Defense		Industrial		Corporate		Total
Facility related charges	Facility related charges	$	10	$	1,632	$	0	$	1,642	Facility related charges	$	19	$	0	$	0	$	19
Employee related charges	Employee related charges	0		1,058		183		1,241		Employee related charges	169		242		158		569
Total restructuring charges, net	Total restructuring charges, net	$	10	$	2,690	$	183	$	2,883	Total restructuring charges, net	$	188	$	242	$	158	$	588

Accrued restructuring charges as of December 31, 2019								$	5,199
Total charges, net (shown above)								2,883
Charges paid / settled, net								(4,154)
Accrued restructuring charges as of March 29, 2020								$	3,928

											Restructuring charges, net
											As of and for the Six Months Ended June 28, 2020
											Aerospace & Defense		Industrial		Corporate		Total
Facility related expenses										Facility related expenses	$	30	$	0	$	0	$	30
Employee related expenses										Employee related expenses	169		2,932		340		3,441
Total restructuring charges, net										Total restructuring charges, net	$	199	$	2,932	$	340	$	3,471

Accrued restructuring charges as of December 31, 2019										Accrued restructuring charges as of December 31, 2019							$	5,199
Total year to date charges, net (shown above)										Total year to date charges, net (shown above)							3,471
Charges paid / settled, net										Charges paid / settled, net							(5,560)
Accrued restructuring charges as of June 28, 2020										Accrued restructuring charges as of June 28, 2020							$	3,110

Descriptions of the restructuring actions is provided in the section titled "Restructuring Programs Summary" that follows.

Restructuring Programs Summary

The Company recorded ~~$2.1~~$2.3 million and $4.3 million of restructuring charges during the three and six months ended ~~April~~July 4, 2021, respectively, to reduce expenses, primarily through reductions in force across both administrative functions and manufacturing operations. The Company initiated plans in Q1Q2 2021 to restructure employees at certain sites, and recognized ~~$1.2~~$2.2 million of charges in connection with these plans in the current quarter. The Company incurred additional charges of ~~$0.9~~$0.1 million, to restructure operations in the current quarter, from plans initiated in 2020. Included in cost of revenues on the condensed consolidated statements of operations is $0.9 million for inventory write downs related to the exit of businesses and consolidation of facilities in the Industrial segment.

During the three and six months ended ~~March 29,~~June 28, 2020, the Company recorded ~~$2.9~~$0.6 million and $3.5 million of restructuring charges, ~~principally in the Industrial segment,~~respectively, to reduce expenses primarily through reductions in force in manufacturing and ~~the consolidation of sales~~administrative operations.

(6) Inventories

Inventories consisted of the following (in thousands):


		April 4, 2021		December 31, 2020			July 4, 2021		December 31, 2020
Raw materials	Raw materials	$	63,935	$	63,255	Raw materials	$	59,810	$	63,255
Work in process	Work in process	50,494		45,867		Work in process	56,252		45,867
Finished goods	Finished goods	20,862		19,962		Finished goods	19,950		19,962
Total inventories	Total inventories	$	135,291	$	129,084	Total inventories	$	136,012	$	129,084

(7) Goodwill and Intangibles, net

The following table shows goodwill by segment as of December 31, 2020 and ~~April~~July 4, 2021 (in thousands):


		Aerospace & Defense		Industrial		Total			Aerospace & Defense		Industrial		Total
Goodwill as of December 31, 2020	Goodwill as of December 31, 2020	$	57,574	$	101,370	$	158,944	Goodwill as of December 31, 2020	$	57,574	$	101,370	$	158,944
Business divestiture								Business divestiture	—		(755)		(755)
Currency translation adjustments								Currency translation adjustments	(45)		(1,359)		(1,404)
Goodwill as of July 4, 2021								Goodwill as of July 4, 2021	$	57,529	$	99,256	$	156,785

Currency translation adjustments		(61)		(1,966)		(2,027)
Goodwill as of April 4, 2021		$	57,513	$	99,404	$	156,917

The movement in goodwill for business divestiture relates to the allocation of goodwill to the carrying value of the Heater and Control Valve businesses divested in the second quarter of 2021.

The Company performs an impairment assessment for goodwill at the reporting unit level on an annual basis ~~as of~~during the ~~end of our October month end,~~fourth quarter, or more frequently if circumstances warrant. At ~~April~~July 4, 2021, the Company performed a review and determined there were no triggering events requiring an impairment assessment.

The table below presents gross intangible assets and the related accumulated amortization as of ~~April~~July 4, 2021 (in thousands):


		Gross Carrying Amount		Accumulated Amortization		Net Carrying Value			Gross Carrying Amount		Accumulated Amortization		Net Carrying Value
Patents	Patents	$	5,368	$	(5,368)	$	0	Patents	$	5,368	$	(5,368)	$	0
Customer relationships	Customer relationships	305,774		(118,096)		187,678		Customer relationships	307,406		(125,932)		181,474
Acquired technology	Acquired technology	136,974		(63,317)		73,657		Acquired technology	137,555		(66,957)		70,598

Total Amortized Intangibles	Total Amortized Intangibles	$	448,116	$	(186,781)	$	261,335	Total Amortized Intangibles	$	450,329	$	(198,257)	$	252,072

Non-amortized intangibles (primarily trademarks and trade names)		$	76,529	$	0	$	76,529
Non-amortized intangibles (trademarks and trade names)								Non-amortized intangibles (trademarks and trade names)	$	76,885	$	0	$	76,885
Total Non-Amortized Intangibles	Total Non-Amortized Intangibles	$	76,529	$	—	$	76,529	Total Non-Amortized Intangibles	$	76,885	$	—	$	76,885
Net carrying value of intangible assets	Net carrying value of intangible assets					$	337,864	Net carrying value of intangible assets					$	328,957

The table below presents estimated remaining amortization expense for intangible assets recorded as of ~~April~~July 4, 2021 (in thousands):

2021 2022 2023 2024 2025 After 2025
Estimated amortization expense $ 31,476 $ 36,980 $ 32,422 $ 28,488 $ 24,931 $ 107,038


	2021		2022		2023		2024		2025		After 2025
Estimated amortization expense	$	21,086	$	37,175	$	32,590	$	28,634	$	25,052	$	107,535

(8) Segment Information

~~Our~~The Company's Chief Operating Decision Maker (the "CODM") evaluates segment operating performance using segment operating income. Segment operating income is defined as GAAP operating income excluding intangible amortization and amortization of fair value step-ups of inventory and fixed assets from acquisitions completed subsequent to December 31, 2011, the impact of restructuring related inventory write-offs, impairment charges and special charges or gains. The Company also refers to this measure as adjusted operating income. The Company uses this measure because it helps management understand and evaluate the segments’ core operating results and serves as the basis for determining incentive compensation achievement.

During the quarter ended March 29, 2020, the Company divested its I&S business, which was previously part of the Energy segment. See Note 5, Special and Restructuring Charges (Recoveries), net for additional information on this divestiture. In light of this divestiture, effective March 29, 2020, the Company realigned its segments by eliminating the Energy segment and moving the remaining businesses into the Industrial segment. Following the realignment the new reporting segments are Industrial and Aerospace & Defense, which is the level at which the CODM regularly reviews operating results.

The following table presents certain reportable segment information (in thousands):


		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Net revenues	Net revenues						Net revenues
Aerospace & Defense	Aerospace & Defense	$	60,001	$	65,493		Aerospace & Defense	$	60,761	$	62,241	$	120,762	$	127,734
Industrial	Industrial	120,654		126,720			Industrial	129,585		123,825		250,239		250,545
Consolidated net revenues	Consolidated net revenues	$	180,655	$	192,213		Consolidated net revenues	$	190,346	$	186,066	$	371,001	$	378,279

Results from continuing operations before income taxes	Results from continuing operations before income taxes						Results from continuing operations before income taxes
Aerospace & Defense - Segment Operating Income	Aerospace & Defense - Segment Operating Income	$	10,706	$	12,494		Aerospace & Defense - Segment Operating Income	$	12,095	$	13,142	$	22,800	$	25,636
Industrial - Segment Operating Income	Industrial - Segment Operating Income	9,735		5,169			Industrial - Segment Operating Income	10,400		12,406		20,135		17,575
Corporate expenses	Corporate expenses	(8,002)		(6,588)			Corporate expenses	(7,850)		(9,664)		(15,852)		(16,252)
Subtotal	Subtotal	12,439		11,075			Subtotal	14,645		15,884		27,083		26,959
Restructuring charges, net	Restructuring charges, net	2,060		2,883			Restructuring charges, net	2,281		588		4,341		3,471
Special charges (recoveries), net	Special charges (recoveries), net	(2,869)		(45,175)			Special charges (recoveries), net	4,522		5,019		1,654		(40,156)
Special and restructuring charges (recoveries), net	Special and restructuring charges (recoveries), net	(809)		(42,292)			Special and restructuring charges (recoveries), net	6,803		5,607		5,995		(36,685)

Restructuring related inventory charges		0		(602)

Restructuring related inventory charges (recoveries), net							Restructuring related inventory charges (recoveries), net	958		0		958		(602)
Impairment charges							Impairment charges	—		—		0		116,182
Acquisition amortization	Acquisition amortization	10,487		10,218			Acquisition amortization	10,498		10,681		20,984		20,898
Acquisition depreciation	Acquisition depreciation	2,375		974			Acquisition depreciation	1,326		980		3,700		1,955
Impairment charges		0		116,182
Restructuring, impairment and other costs, net	Restructuring, impairment and other costs, net	12,862		126,772			Restructuring, impairment and other costs, net	12,782		11,661		25,642		138,433
Consolidated Operating Income (loss)	Consolidated Operating Income (loss)	386		(73,405)			Consolidated Operating Income (loss)	(4,940)		(1,384)		(4,554)		(74,789)
Interest expense, net	Interest expense, net	8,369		9,011			Interest expense, net	7,957		8,486		16,327		17,497
Other expense (income), net	Other expense (income), net	(1,503)		(2,680)			Other expense (income), net	(1,173)		2,144		(2,676)		(536)

(Loss) income from continuing operations before income taxes		$	(6,480)	$	(79,736)
Income (loss) from continuing operations before income taxes							Income (loss) from continuing operations before income taxes	$	(11,724)	$	(12,014)	$	(18,205)	$	(91,750)

		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Capital expenditures	Capital expenditures						Capital expenditures
Aerospace & Defense	Aerospace & Defense	$	1,286	$	640		Aerospace & Defense	$	867	$	686	$	2,152	$	1,327
Industrial	Industrial	2,023		2,225			Industrial	1,457		2,241		3,481		4,557
Corporate	Corporate	153		198			Corporate	(30)		132		123		330
Consolidated capital expenditures	Consolidated capital expenditures	$	3,462	$	3,063		Consolidated capital expenditures	$	2,294	$	3,059	$	5,756	$	6,214

Depreciation and amortization	Depreciation and amortization						Depreciation and amortization
Aerospace & Defense	Aerospace & Defense	$	2,824	$	3,093		Aerospace & Defense	$	2,949	$	3,087	$	5,773	$	6,180
Industrial	Industrial	14,203		12,419			Industrial	13,020		12,742		27,224		25,161
Corporate	Corporate	178		125			Corporate	149		105		326		230
Consolidated depreciation and amortization	Consolidated depreciation and amortization	$	17,205	$	15,637		Consolidated depreciation and amortization	$	16,118	$	15,934	$	33,323	$	31,571

Identifiable assets	Identifiable assets	April 4, 2021		December 31, 2020			Identifiable assets	July 4, 2021		December 31, 2020
Aerospace & Defense	Aerospace & Defense	$	450,280	$	450,597		Aerospace & Defense	$	444,767	$	450,597
Industrial	Industrial	1,359,942		1,378,710			Industrial	1,350,885		1,378,710
Corporate	Corporate	(687,020)		(698,779)			Corporate	(693,651)		(698,779)

Consolidated identifiable assets	Consolidated identifiable assets	$	1,123,202	$	1,130,528		Consolidated identifiable assets	$	1,102,001	$	1,130,528

The total assets for each reportable segment have been reported as the Identifiable Assets for that segment, including inter-segment intercompany receivables, payables and investments in other CIRCOR subsidiaries. Identifiable assets reported in Corporate include both corporate assets, such as cash, deferred taxes, prepaid and other assets, fixed assets, as well as the

elimination of all inter-segment intercompany assets. The elimination of intercompany assets results in negative amounts reported in Corporate for Identifiable Assets.

(9) Financing Arrangements

Fair Value

The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

•Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.

•Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

•Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The aggregate net fair value of the Company's interest rate swap, cross-currency swap, and foreign currency forward contract as of ~~April~~July 4, 2021 and December 31, 2020 are summarized in the table below (in thousands):


		Level 2 - Significant Other Observable Inputs					Significant Other Observable Inputs Level 2
		April 4, 2021		December 31, 2020			July 4, 2021		December 31, 2020

Derivative assets	Derivative assets	$	2,370	$	2,359	Derivative assets	$	2,403	$	2,359
Derivative liabilities	Derivative liabilities	$	(12,467)	$	(17,139)	Derivative liabilities	$	(12,090)	$	(17,139)

The carrying amounts of cash and cash equivalents, restricted cash, trade receivables and trade payables approximate fair value because of the short term maturity of these financial instruments. Cash equivalents are carried at cost which approximates fair value at the balance sheet date and is a Level 1 financial instrument. As of ~~April~~July 4, 2021, the estimated fair value of ~~our~~the Company's gross debt (before netting debt issuance costs) was ~~$533.3~~$522.5 million, compared to carrying cost of ~~$536.9~~$523.0 million. At December 31, 2020 the estimated fair value of ~~our~~the Company's gross debt (before netting debt issuance costs) was $517.3 million, compared to carrying cost of $519.9 million. The Company's outstanding debt balances are characterized as Level 2 financial instruments.

Financial Instruments

As of ~~April~~July 4, 2021 and December 31, 2020, the Company had restricted cash balances of $1.3 million and $1.2 million, respectively. These balances are recorded within prepaid expenses and other current assets on the condensed consolidated balance sheets, and are included within cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows.

The Company has a receivable purchasing agreement with a bank whereby the Company can sell selected accounts receivable and obtain between 90% and 100% of the purchase price upfront, net of applicable discount fee, and the residual amount as the receivables are collected. During the three and six months ended ~~April~~July 4, 2021, the Company sold a total of ~~$8.4~~$9.8 million and $18.2 million respectively, of receivables under the program, receiving ~~$8.2~~$9.3 million and $17.5 million, respectively in upfront cash. During the three and six months ended ~~March 29,~~June 28, 2020, the Company sold a total of ~~$14.5~~$14.7 million and $29.2 million, respectively, of receivables under the program, receiving $13.8 million and ~~received $13.6~~$27.4 million, respectively in ~~cash upfront.~~upfront cash. At ~~April~~

July 4, 2021, a beneficial interest balance of ~~$0.2~~$0.5 million was recorded in prepaid expenses and other current assets on the condensed consolidated balance sheet.

The Company has a cross-currency swap agreement to hedge its net investment in non-U.S. subsidiaries against future volatility in exchange rates between the U.S. dollar and the Euro. The cross-currency swap agreement is pursuant to an International Swaps and Derivatives Association ("ISDA") Master Agreement with Deutsche Bank AG. Should the counterparty cease to be part of the Company's secured lender group, the cross-currency agreement could be terminated early if acceptable substitute collateral arrangements (such as cash) are not put in place. The three-year cross-currency swap has a fixed notional value of

~~$100.0~~ $100.0 million at an annual rate of 2.4065% and a maturity date of July 12, 2022. At inception, the cross-currency swap was designated as a net investment hedge. This hedging agreement mitigates foreign currency exchange rate exposure on the Company's net investment in Euro denominated subsidiaries and is not for speculative trading purposes. The net investment hedge was deemed effective as of quarter-end. As of ~~April~~July 4, 2021 and December 31, 2020, the cross-currency swap had a fair value liability of ~~$2.9~~$4.2 million and $6.2 million, respectively.

The Company has an interest rate swap pursuant to an ISDA Master Agreement with Citizens Bank, National Association. The four-year interest rate swap has a fixed notional value of $400.0 million with a 1% LIBOR floor (in line with the Company's credit agreement) and a maturity date of April 12, 2022. The fixed rate of interest paid by the Company is comprised of ~~our~~the current credit spread of 325 basis points plus 2.6475% for a total interest rate of 5.8975%. The ISDA Master Agreement, together with its related schedules, contains customary representations, warranties, and covenants. The Company has designated the interest rate swap as a qualifying hedging instrument and is treating it as a cash flow hedge for accounting purposes pursuant to ASC 815, Derivatives and Hedging. As of ~~April~~July 4, 2021 and December 31, 2020, the interest rate swap had a fair value liability of ~~$7.1~~$5.5 million and $8.6 million, respectively.

As of ~~April~~July 4, 2021, the Company had one EUR/SEK foreign currency forward contract with a notional value of EUR 10 million. There were no open forward contracts as of December 31, 2020. The fair value ~~liability~~ of the derivative forward contract at July 4, 2021 was ~~approximately $0.1 million and is included in accrued expenses and other current liabilities on our condensed consolidated balance sheet as of April 4, 2021. Our~~immaterial. The Company's forward hedge contract falls within Level 2 of the fair value hierarchy, in accordance with ASC Topic 820. For the three and six months ended ~~April~~July 4, 2021, the realized and unrealized loss associated with this contract was ~~$0.3 million, respectively.~~immaterial. The intent of the foreign currency forward contract is to mitigate the risk of foreign exchange gains and losses on Euro-denominated balances at one of ~~our~~the Company's non-Euro denominated functional currency entities. The forward contracts does not qualify for hedge accounting treatment. Any gains and losses are recognized as a component of other expense in ~~our~~the condensed consolidated statements of operations.

The aggregate net fair value of the interest rate swap, cross-currency swap, and foreign currency forward contract was a net liability position of ~~$10.1~~$9.7 million and $14.8 million at ~~April~~July 4, 2021 and December 31, 2020, respectively. These balances are recorded in other non-current liabilities of ~~$5.8~~$6.6 million, accrued expenses and other current liabilities of ~~$6.7~~$5.5 million, and prepaid expenses and other current assets of $2.4 million on ~~our~~the condensed consolidated balance sheet as of ~~April~~July 4, 2021. As of December 31, 2020, these balances are recorded in other non-current liabilities of $10.6 million, accrued expenses and other current liabilities of $6.5 million, and prepaid expenses and other current assets of $2.4 million on ~~our~~the Company's consolidated balance sheet.

The amount of gains (loss) recognized in other comprehensive (loss) income ("OCI") and reclassified from accumulated other comprehensive (loss) income ("AOCI") to earnings are summarized below (in thousands):


		Three Months Ended					Three Months Ended		Six Months Ended
		April 4, 2021		March 29, 2020			July 4, 2021		July 4, 2021
Amount of (loss) recognized in OCI	Amount of (loss) recognized in OCI	$	(134)	$	(4,105)	Amount of (loss) recognized in OCI	$	(105)	$	(239)

Amount of (loss) reclassified from AOCI to earnings (interest expense, net)	Amount of (loss) reclassified from AOCI to earnings (interest expense, net)	$	(1,720)	$	(1,093)	Amount of (loss) reclassified from AOCI to earnings (interest expense, net)	$	(1,667)	$	(3,387)

Amounts expected to be reclassified from AOCI into interest expense in the next 12 months is a loss of ~~$6.5~~$5.1 million. Interest expense (including the effects of the cash flow hedges) related to the portion of the Company's term loan subject to the aforementioned interest-rate swap agreement was ~~$6.2~~$6.0 million and $12.2 million for the three and six months ended ~~April~~July 4, ~~2021.~~2021 respectively.

Debt

respectively. The Company made interest payments of ~~$7.6~~$15.6 million and ~~$8.8~~$17.2 million during the ~~three~~six months ended ~~April~~July 4, 2021, and ~~March 29,~~June 28, 2020, respectively.

~~During the three months ended March 29, 2020, the Company paid down $161.8 million on its term loan from proceeds received through the sale of the I&S business.~~ On March 20, 2020, the Company drew down $80 million on its line of credit due to concerns about possible disruptions to global capital markets stemming from COVID-19. The Company has since paid down its revolving credit facility balance by ~~$35.1~~$49.0 million for a current balance of ~~$44.9~~$31.0 million as of ~~April~~July 4, 2021.

During the first quarter of 2020, the Company amended its term loan to lower the interest rate associated with the applicable margin calculation. The new terms lower the interest rate on the Company's term loan from LIBOR plus an applicable margin of 3.5% to LIBOR plus an applicable margin of 3.25%, based on its existing corporate family rating from Moody's. The applicable margin reduces to LIBOR plus an applicable margin of 3.0%, with a corporate family rating from Moody's of B1 or better.

As part of the debt repricing, the Company's outstanding loan balance was reallocated amongst the lender group. The Company evaluated the changes in outstanding loan balance for each individual lender to determine the amount of capitalized debt issuance costs that required adjustment. Through this exercise, the Company determined that certain creditors under the original term loan did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $3.5 million in the first quarter of during Q1 2020 which was recorded to Special and restructuring charges (recoveries), net, on the condensed consolidated statement of operations. For the remainder of the creditors, this transaction was accounted for as a modification. The Company accounted for the amendment pursuant to ASC 470, subtopic 50-40, and third-party costs of $0.2 million related to this transaction were expensed and $0.3 million of lender fees were recorded as a reduction to debt representing deferred issuance costs.

(10) Guarantees and Indemnification Obligations

As permitted under Delaware law, the Company has agreements whereby it indemnifies certain of its officers and directors for certain events or occurrences while the officer or director is, or was, serving at its request in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. However, it has directors’ and officers’ liability insurance policies that insure it with respect to certain events covered under the policies and should enable it to recover a portion of any future amounts paid under the indemnification agreements. The Company has 0 liabilities recorded from those agreements as of ~~April~~July 4, 2021.

The Company records provisions for the estimated cost of product warranties, primarily from historical information, at the time product revenue is recognized. The Company also records provisions with respect to any significant individual warranty issues as they arise. While the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, utilization levels, material usage, service delivery costs incurred in correcting a product failure, and supplier warranties on parts delivered to us. Should actual product failure rates, utilization levels, material usage, service delivery costs or supplier warranties on parts differ from ~~our~~the Company's estimates, revisions to the estimated warranty liability would be required.

The following table sets forth information related to product warranty reserves for the ~~three~~six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 (in thousands):


	~~Three Months Ended~~

~~Balance beginning December 31, 2020~~	$	~~2,206~~
~~Provisions~~	~~548~~
~~Claims settled~~	~~(629)~~

~~Currency translation adjustment~~	~~(21)~~
~~Balance ending April 4, 2021~~	$	~~2,104~~

~~Balance beginning December 31, 2019~~	$	~~1,642~~
~~Provisions~~	~~368~~
~~Claims settled~~	~~(682)~~

~~Currency translation adjustment~~	~~(29)~~
~~Balance ending March 29, 2020~~	$	~~1,299~~


	Six Months Ended
		July 4, 2021		June 28, 2020

Balance beginning		$	2,206	$	1,642
Provisions		1,888		1,001
Claims settled		(1,531)		(1,126)

Currency translation adjustment		(19)		(10)
Balance ending		$	2,544	$	1,507

Warranty obligations are recorded within Accrued expenses and other current liabilities on the condensed consolidated balance sheets.

(11) Commitments and Contingencies

The Company is subject to various legal proceedings and claims pertaining to matters such as product liability or contract disputes. The Company is also subject to other proceedings and governmental inquiries, inspections, audits or investigations pertaining to issues such as tax matters, patents and trademarks, pricing, business practices, governmental regulations, employment and other matters. Although the results of litigation and claims cannot be predicted with certainty, ~~we expect~~the Company expects that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on ~~our~~the Company's financial condition, results of operations or liquidity. During the ~~three~~six months ended ~~April~~July 4, 2021, the Company recognized recoveries for a business interruption insurance claim in the amount of ~~$0.7~~$0.8 million, which is classified in the selling, general and administrative expenses on the condensed consolidated statement of operations.

Asbestos-related product liability claims continue to be filed against two of ~~our~~the Company's subsidiaries: Spence Engineering Company, Inc. (“Spence”), the stock of which the Company acquired in 1984; and CIRCOR Instrumentation Technologies, Inc. (f/k/a Hoke, Inc.) (“Hoke”), the stock of which it acquired in 1998. The Hoke subsidiary was divested in January 2020 through ~~our~~the sale of the I&S business. However, the Company has indemnified the buyer for asbestos-related claims that are made

against Hoke. Due to the nature of the products supplied by these entities, the markets they serve and ~~our~~the Company's historical experience in resolving these claims, the Company does not expect that these asbestos-related claims will have a material adverse effect on the financial condition, results of operations or liquidity of the Company.

During the second quarter of 2021 the Company was notified of a contract termination by one of its Industrial segment customers. The basis for this termination is under dispute and the ultimate outcome of this matter is uncertain. The Company has a net receivable in the amount of $4.6 million as of July 4, 2021 relating to this contract. Further, the Company has outstanding guarantees of its performance under the contract in the aggregate amount of $3.4 million. Should the negotiation or settlement process be unfavorable for the Company, the Company is exposed to risk of loss for some or all of the net receivable under the contract, performance guarantees and potential future claims should any be asserted.

Standby Letters of Credit

The Company executes standby letters of credit, which include bid bonds and performance bonds, in the normal course of business to ensure performance or payments to third parties. The aggregate notional value of these instruments at ~~April~~July 4, 2021 was ~~$27.3~~$31.4 million of which ~~$19.6~~$25.1 million was syndicated under ~~our~~the Company's credit agreement. This compares with aggregate notional value of $39.3 million of which $30.4 million was syndicated under ~~our~~the credit agreement as of December 31, 2020. ~~The Company believes that the likelihood of demand for a significant payment relating to the outstanding instruments is remote.~~ These instruments generally have expiration dates ranging from less than 1 month to 5 years from ~~April~~July 4, 2021.

(12) Retirement Plans

The following table sets forth the components of total net periodic benefit cost (income) of the Company’s defined benefit pension plans and other post-retirement employee benefit plans (in thousands):


		Three Months Ended				Three Months Ended				Six Months Ended
		April 4, 2021		March 29, 2020				July 4, 2021		June 28, 2020		July 4, 2021		June 28, 2020
Pension Benefits - U.S. Plans	Pension Benefits - U.S. Plans						Pension Benefits - U.S. Plans

Interest cost	Interest cost	$	773	$	1,398		Interest cost	$	773	$	1,396	$	1,545	$	2,795
Expected return on plan assets	Expected return on plan assets	(2,629)		(2,747)			Expected return on plan assets	(2,628)		(2,746)		(5,256)		(5,493)
Amortization	Amortization	51		43			Amortization	50		42		101		85
Net periodic benefit income	Net periodic benefit income	$	(1,805)	$	(1,306)		Net periodic benefit income	$	(1,805)	$	(1,308)	$	(3,610)	$	(2,613)

Pension Benefits - Non-U.S. Plans	Pension Benefits - Non-U.S. Plans						Pension Benefits - Non-U.S. Plans
Service cost	Service cost	$	823	$	692		Service cost	$	823	$	667	$	1,646	$	1,359
Interest cost	Interest cost	247		339			Interest cost	246		321		493		660
Expected return on plan assets	Expected return on plan assets	(156)		(194)			Expected return on plan assets	(158)		(175)		(314)		(370)
Amortization	Amortization	179		31			Amortization	180		(31)		359		0
Net periodic benefit cost	Net periodic benefit cost	$	1,093	$	868		Net periodic benefit cost	$	1,091	$	782	$	2,184	$	1,649

Other Post-Retirement Benefits	Other Post-Retirement Benefits						Other Post-Retirement Benefits
Service cost	Service cost	$	1	$	0		Service cost	$	1	$	0	$	2	$	0
Interest cost	Interest cost	42		66			Interest cost	42		66		84		132

Net periodic benefit cost	Net periodic benefit cost	$	43	$	66		Net periodic benefit cost	$	43	$	66	$	86	$	132

The periodic benefit service costs are included in both costs of revenues, as well as selling, general, and administrative costs, while the remaining net periodic benefit costs are included in other expense (income), net in ~~our~~the condensed consolidated statements of operations for the quarters ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020.

The Company did not make any employer contributions to the Company's U.S. or non-U.S. based defined benefit pension plans during the three and six months ended ~~April~~July 4, 2021. This is consistent with the three and six months ended ~~March 29,~~June 28, 2020, in which the Company also did not make any contributions to the defined benefit pension plans.

(13) Income Taxes

The provision for (benefit from) income taxes to loss from continuing operations is as follows (in thousands):


		Three Months Ended							Three Months Ended						Six Months Ended
		April 4, 2021			March 29, 2020				July 4, 2021			June 28, 2020			July 4, 2021			June 28, 2020
Loss from Continuing Operations Before Income Taxes	Loss from Continuing Operations Before Income Taxes	$	(6,480)		$	(79,736)		Loss from Continuing Operations Before Income Taxes	$	(11,724)		$	(12,014)		$	(18,205)		$	(91,750)
Effective tax rate	Effective tax rate	(6.2)		%	(10.5)		%	Effective tax rate	(25.3)		%	181.2		%	(18.5)		%	14.6		%
Provision for (benefit from) income taxes	Provision for (benefit from) income taxes	$	400		$	8,374		Provision for (benefit from) income taxes	$	2,961		$	(21,769)		$	3,360		$	(13,395)

The Company is required to compute income tax expense in each jurisdiction in which it operates. This process requires the Company to project its current tax liability and estimate its deferred tax assets and liabilities, including net operating loss (“NOL”) and tax credit carryforwards. In assessing the ability to realize the net deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the net deferred tax assets will not be realized.

The effective tax rate for the three months ended ~~April~~July 4, 2021, differed from the U.S. federal statutory rate of 21% primarily due to adjustments to the domestic and foreign valuation allowances and adjustments related to uncertain tax positions. The effective tax rate for the three months ended ~~March 29,~~June 28, 2020, differed from the U.S. federal statutory rate primarily due to non-deductible expenses, goodwill impairment and dispositions. The effective tax rate for the six months ended July 4, 2021 differed from the U.S. federal statutory rate of 21% primarily due to adjustments to the domestic and foreign valuation allowances and an adjustment related to stock compensation. The effective tax rate for the six months ended June 28, 2020 differed from the U.S. statutory tax rate of 21% primarily due to non-deductible expenses, goodwill impairment and dispositions. In 2020 the Company recorded a full valuation allowance in the USU.S. and Germany. The Company intends to continue maintaining valuation allowances on these deferred tax assets until there is sufficient evidence to support the release of all or some portion of these allowances.

As of ~~April~~July 4, 2021 and December 31, 2020, the Company had ~~$1.5~~$1.0 million and $1.1 million, respectively, of unrecognized tax benefits including penalty and interest, all of which would affect ~~our~~the Company's effective tax rate if recognized in any future period.

(14) Share-Based Compensation

As of ~~April~~July 4, 2021, the Company had ~~640,010~~636,232 stock options and ~~742,390~~612,882 Restricted Stock Unit Awards ("RSU Awards") and Restricted Stock Unit Management Stock Plan Awards ("RSU MSPs") outstanding. On May ~~9, 2019, our~~25, 2021 at the Company's annual meeting, the Company's shareholders approved an amendment to the 2019 Stock Option and Incentive Plan (the "2019 Plan") atto increase the ~~Company's annual meeting~~number of shares available for issuance by 1,000,000 shares, which ~~was adopted, subject to shareholder approval, by the Company's board of directors on February 20, 2019.~~will become available for issuance upon registration. The 2019 Plan now authorizes issuance of up to ~~1,000,000~~2,000,000 shares of common stock (subject to adjustment for stock splits and similar events). Under the 2019 Plan, there were ~~205,045~~226,790 shares available for grant as of ~~April~~July 4, 2021.

During the ~~three~~six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020, there were no stock options granted.

For additional information regarding the historical issuance of stock options, refer to Note 13 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.

~~During~~

A summary of the ~~three months ended April 4, 2021 and March 29, 2020, the Company granted 233,618 and 552,010~~ RSU Awards ~~with approximate fair values of $40.85~~ and ~~$12.70 per~~ RSU ~~Award, respectively. During the three months ended April 4, 2021 and March 29, 2020, the Company granted performance-based RSU Awards as part of the overall mix of RSU Awards.~~ MSPs unit activity is presented below:


	RSU Awards	Weighted Average Price RSUs		RSU MSP Awards	Weighted Average Price RSU MSPs
Outstanding as of December 31, 2020	666,627	$	17.11	78,298	$	24.99
Granted	239,320	$	40.78	31,248	$	26.68
Vested	(326,173)	$	17.12	(28,971)	$	35.11
Forfeited	(43,174)	$	23.97	(4,293)	$	23.67
Outstanding as of July 4, 2021	536,600	$	27.11	76,282	$	24.17
Vested and Deferred	1,338	$	42.62	3,611	$	22.53


	RSU Awards	Weighted Average Price RSUs		RSU MSP Awards	Weighted Average Price RSU MSPs
Outstanding as of December 31, 2019	274,959	$	38.51	106,602	$	28.06
Granted	606,679	$	12.60	0	$	0
Vested	(81,162)	$	36.95	(24,143)	$	39.62
Forfeited	(98,868)	$	32.46	(3,634)	$	23.48
Outstanding as of June 28, 2020	701,608	$	17.14	78,825	$	24.98
Vested and Deferred	1,450	$	46.91	1,996	$	36.02

Of the ~~233,618~~239,320 RSU Awards granted during the ~~three~~six months ended ~~April~~ July 4, 2021, 70,933 are performance-based RSU Awards. This compares to 109,278 performance-based RSU Awards granted during the ~~three~~six months ended ~~March 29,~~ June 28, 2020. ~~In 2021, these~~The performance-based RSU Awards granted ~~with~~in 2021 include a market condition ~~are~~ based on the Company's total shareholder return relative

to a subset of the S&P 600 SmallCap Industrial Companies over a three year performance period. The target payout range for the 2021 award is 0% to 200% with a cap not to exceed 600% of the target value on the grant date. The 2021 performance-based RSUs are valued using a Monte Carlo Simulation model to account for the market condition on grant date. ~~In 2020, the~~The performance-based RSUs granted in 2020 include metrics for achieving Adjusted Operating Margin and Adjusted Measurement Cash Flow with target payouts ranging from 0% to 200%. Of the different performance-based RSU tranches without a market condition, the Company anticipates approximately 6%8% overall achievement and probability to vest.

There were 31,248 RSU MSPs granted during the three months ended April 4, 2021. RSU MSPs granted during the three months ended April 4, 2021 had a per unit discount of $13.14 per share representing fair value. No RSU MSPs were granted during the three months ended March 29, 2020.

Compensation expense related to the Company's share-based plans for the ~~three~~six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 was ~~$1.4~~$2.9 million and ~~$0.7~~$2.5 million, respectively. The increase in 2021 expense is primarily due to higher performance-based RSU expense. Compensation expense for ~~three~~six months ended ~~April~~July 4, 2021 was recorded in selling, general and administrative expenses. Compensation expense for the ~~three~~six months ended ~~March 29,~~June 28, 2020 was recorded as follows: ~~$0.6~~$2.2 million in selling, general and administrative expenses, ~~and~~ $0.1 million in special charges related to the sale of the Company's I&S business, and $0.2 million in discontinued operations related to the sale of the Company's DV business. The special charges relate to the accelerated vesting of awards as a result of the sale transactions. As of ~~April~~July 4, 2021, there were ~~$13.6~~$11.6 million of total unrecognized compensation costs related to the Company's outstanding share-based compensation arrangements. That cost is expected to be recognized over a weighted average period of ~~2.5~~2.3 years.

The weighted average contractual term for stock options outstanding and options exercisable as of ~~April~~July 4, 2021 was ~~2.9~~2.7 years and ~~2.8~~2.5 years, respectively. The aggregate intrinsic value of stock options exercised during the three months ended April 4, 2021 was insignificant. The aggregate intrinsic value of stock options outstanding and exercisable as of April 4, 2021 was $0.2 million and $0.2 million, respectively.

The aggregate intrinsic value of RSU Awards settled during the ~~three~~six months ended ~~April~~July 4, 2021 was ~~$8.3~~$11.8 million and the aggregate intrinsic value of RSU Awards outstanding as of ~~April~~July 4, 2021 was ~~$23.4 million.~~

~~The aggregate intrinsic values of RSU MSPs settled during the three months ended April 4, 2021 was $0.2 million and the aggregate intrinsic value of RSU MSPs outstanding as of April 4, 2021 was $0.9~~$17.2 million.

The Company also grants cash settled stock unit awards to some of its international employee participants. Cash settled stock unit award related compensation ~~costs~~cost for the ~~three~~six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 ~~were~~was immaterial.

(15) Accumulated Other Comprehensive Loss

The following table summarizes the changes in accumulated other comprehensive loss, net of tax, which is reported as a component of shareholders' equity, for the ~~three~~six months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 (in thousands):

Foreign Currency Translation Adjustments Pension, net Derivative Total
Balance as of December 31, 2020 $ (46,899) $ (33,359) $ (5,710) $ (85,968)
Other comprehensive (loss) income (3,594) 60 1,586 (1,948)
Balance as of April 4, 2021
$ (50,493) $ (33,299) $ (4,124) $ (87,916)
Balance as of December 31, 2019 $ (53,848) $ (19,513) $ (6,906) $ (80,267)
Other comprehensive (loss) income (20,325) 39 (2,320) (22,606)
Balance as of March 29, 2020 $ (74,173) $ (19,474) $ (9,226) $ (102,873)


	Foreign Currency Translation Adjustments		Pension, net		Derivative		Total
Balance as of December 31, 2020	$	(46,899)	$	(33,359)	$	(5,710)	$	(85,968)



Other comprehensive (loss) income	(3,364)		111		3,148		(105)
Balance as of July 4, 2021	$	(50,263)	$	(33,248)	$	(2,562)	$	(86,073)

Balance as of December 31, 2019	$	(53,848)	$	(19,513)	$	(6,906)	$	(80,267)
Other comprehensive (loss) income	(6,235)		82		(1,565)		(7,718)
Balance as of June 28, 2020	$	(60,083)	$	(19,431)	$	(8,471)	$	(87,985)

(16) Income (Loss) Per Common Share ("EPS")

For the three and six months ended ~~April~~July 4, 2021, and ~~March 29,~~June 28, 2020, outstanding stock options, RSU Awards and RSU MSPs were not included in the calculation of dilutive EPS because to do so would be anti-dilutive. Certain stock options to purchase

common shares and restricted stock units ("RSUs") were anti-dilutive. For the three months ended ~~April~~July 4, 2021, there were ~~870,829~~811,422 anti-dilutive stock options, RSUs, and RSU MSPs with exercise prices ranging from $33.63 to $60.99. For the three months ended ~~March 29,~~June 28, 2020, there were ~~417,932~~773,708 anti-dilutive stock options, RSUs, and RSU MSPs with exercise prices ranging from ~~$33.63~~$19.41 to $71.56.


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains certain statements that are “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “may,” “hope,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” “continue,” and other expressions, which are predictions of or indicate future events and trends and which do not relate to historical matters, identify forward-looking statements, although not all forward-looking statements are accompanied by such words. We believe that it is important to communicate our future expectations to our stockholders, and we, therefore, make forward-looking statements in reliance upon the safe harbor provisions of the Act. However, there may be events in the future that we are not able to accurately predict or control and our actual results may differ materially from the expectations we describe in our forward-looking statements. Forward-looking statements, including statements about outlook for the ~~second~~third quarter, the expected and potential direct or indirect impacts of the COVID-19 pandemic on our business, the realization of cost reductions from restructuring activities and expected synergies, the number of new product launches and future cash flows from operating activities, involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the duration and severity of the COVID-19 pandemic and its impact on the global economy; changes in the price of and demand for oil and gas in both domestic and international markets; any adverse changes in governmental policies; variability of raw material and component pricing; changes in our suppliers’ performance; fluctuations in foreign currency exchange rates; changes in tariffs or other taxes related to doing business internationally; our ability to hire and retain key personnel; our ability to operate our manufacturing facilities at efficient levels including our ability to prevent cost overruns and reduce costs; our ability to generate increased cash by reducing our working capital; our prevention of the accumulation of excess inventory; our ability to successfully implement our divestiture; restructuring or simplification strategies; fluctuations in interest rates; our ability to successfully defend product liability actions; the outcome of litigation or claims made against us; as well as the uncertainty associated with the current worldwide economic conditions and the continuing impact on economic and financial conditions in the United States and around the world, including as a result of COVID-19, natural disasters, terrorist attacks and other similar matters. We advise you to read further about these and other risk factors set forth in Part II, Item 1A of this Quarterly Report on Form 10-Q and Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2020, which is filed with the Securities and Exchange Commission ("SEC") and is available on the SEC's website at www.sec.gov. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Company Overview

CIRCOR is one of the world’s leading providers of mission critical flow control products and services for the Industrial and Aerospace & Defense markets. The Company has a product portfolio of market-leading brands serving its customers’ most demanding applications. CIRCOR markets its solutions directly and through various sales and distribution partners to more than 14,000 customers in approximately 100 countries. The Company has a global presence with approximately 3,100 employees and is headquartered in Burlington, Massachusetts.

We organize our reporting structure into two segments: Aerospace & Defense and Industrial. Both the current and prior periods are reported under these two segments.

COVID-19

The Company's Aerospace & Defense segment has been and continues to be significantly impacted by the COVID-19 pandemic, primarily in our Commercial Aerospace business. We expect that the commercial aerospace end markets will improve in 2021 compared to 2020, but that a recovery to pre-pandemic levels of demand will depend on air framer production rates and could take several years. Our Defense business has been less impacted by the pandemic, and we expect continued growth in this end market driven by our positions on key U.S. defense programs, including the Joint Strike Fighter and Columbia class submarines, and new product introductions. We continue to focus on increasing growth in our global aftermarket.

The Company's Industrial reporting segment has been and continues to be significantly impacted by the COVID-19 pandemic. In 2021, we expect modest growth in the General Industrial sector led by chemical and machinery applications with a weaker recovery in construction and mining. While our commercial marine sector continues to be constrained, we do expect to experience growth as the regulatory environment could cause demand for our products. We expect that our mid-stream and downstream oil and gas customers will continue to prioritize spending on critical safety and maintenance, but we expect that larger capital expenditures will continue to be delayed. We expect to experience higher demand for our products that serve the power generation markets with particular strength in Asia and in our global aftermarket.

Basis of Presentation

All significant intercompany balances and transactions have been eliminated in consolidation.

We operate and report financial information using a fiscal year ending December 31. The data periods contained within our Quarterly Reports on Form 10-Q reflect the results of operations for the 13-week, 26-week and 39-week periods which generally end on the Sunday nearest the calendar quarter-end date.

Critical Accounting Policies

Critical accounting policies are those that are both important to the accurate portrayal of a company’s financial condition and results and require subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no significant changes from the methodology applied by management for critical accounting policies and estimates previously disclosed in our most recent Annual Report on Form 10-K, except as updated by Note 2 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q with respect to newly adopted accounting standards. The expenses and accrued liabilities or allowances related to certain of our accounting policies are initially based on our best estimates at the time of original entry in our accounting records. Adjustments are recorded when our actual experience, or new information concerning our expected experience, differs from underlying initial estimates. These adjustments could be material if our actual or expected experience were to change significantly in a short period of time. We make frequent comparisons of actual experience and expected experience in an effort to mitigate the likelihood of material adjustments.

Some of the more significant estimates, which are impacted by management's estimates and assumptions regarding the effects of COVID-19, relate to estimated total costs for ongoing long-term revenue contracts where transfer of control occurs over time, inventory valuation, share-based compensation, amortization and impairment of long-lived assets, income taxes (including valuation allowance), fair value of disposal group, pension ~~benefits~~benefit obligations, penalty accruals for late shipments, asset valuations, and product warranties. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ materially from those estimates.

Results of Operations

~~First~~Second Quarter 2021 Compared with ~~First~~Second Quarter 2020

Consolidated Operations


		Three Months Ended													Three Months Ended
(in thousands)	(in thousands)	April 4, 2021		March 29, 2020		Total Change		Divestiture		Operations		Foreign Exchange		(in thousands)	July 4, 2021		June 28, 2020		Total Change		Divestiture		Operations		Foreign Exchange
Net Revenues	Net Revenues													Net Revenues
Aerospace & Defense	Aerospace & Defense	$	60,001	$	65,493	$	(5,492)	$	—	$	(6,657)	$	1,165	Aerospace & Defense	$	60,761	$	62,241	$	(1,480)	$	—	$	(2,892)	$	1,412
Industrial	Industrial	120,654		126,720		(6,066)		(4,900)		(7,523)		6,357		Industrial	129,585		123,825		5,760		—		(1,669)		7,429
Consolidated Net Revenues	Consolidated Net Revenues	$	180,655	$	192,213	$	(11,558)	$	(4,900)	$	(14,180)	$	7,522	Consolidated Net Revenues	$	190,346	$	186,066	$	4,280	$	—	$	(4,561)	$	8,841

Net revenues for the three months ended ~~April~~July 4, 2021 were ~~$180.7~~$190.3 million, ~~a decrease~~an increase of ~~$11.6~~$4.3 million, or 6%2% as compared to the three months ended ~~March 29,~~June 28, 2020, primarily driven by ~~lower revenue as a result of divestitures of 3%, and~~ operational decreases of 7%2% due in part to the ongoing impact of COVID-19 on the global economy and the markets in which CIRCOR operates, ~~partially~~ offset by favorable currency translation of 4%5%. Although the Company's Defense business has remained stable during the pandemic, the Company's commercial aerospace and industrial markets continue to be impacted by COVID-19 as compared to the three months ended March 29, 2020.

Segment Results

In accordance with accounting principles generally accepted in the U.S. ("GAAP"), a company's segment reporting should follow how the business is reviewed by its CODM, which is the function that allocates the resources of the enterprise and assesses the performance of the Company's reportable operating segments. CIRCOR has determined that the CODM is its Chief Executive Officer ("CEO"), as the CEO has the ultimate responsibility for CIRCOR's strategic decision-making and resource allocation.

Our CODM evaluates segment operating performance using segment operating income. Segment operating income is defined as GAAP operating income excluding intangible amortization and amortization of fair value step-ups of inventory and fixed assets from acquisitions completed subsequent to December 31, 2011, the impact of restructuring related inventory write-offs, impairment charges and special charges or gains. The Company also refers to this measure as adjusted operating income. The Company uses this measure because it helps management understand and evaluate the segments’ core operating results and serves as the basis for determining incentive compensation achievement.

The following table presents certain reportable segment information:


		Three Months Ended							Three Months Ended
(in thousands, except percentages)	(in thousands, except percentages)	April 4, 2021			March 29, 2020			(in thousands, except percentages)	July 4, 2021			June 28, 2020
Net revenues	Net revenues							Net revenues
Aerospace & Defense	Aerospace & Defense	$	60,001		$	65,493		Aerospace & Defense	$	60,761		$	62,241
Industrial	Industrial	120,654			126,720			Industrial	129,585			123,825
Consolidated net revenues	Consolidated net revenues	$	180,655		$	192,213		Consolidated net revenues	$	190,346		$	186,066

Loss from continuing operations before income taxes	Loss from continuing operations before income taxes							Loss from continuing operations before income taxes
Aerospace & Defense - Segment Operating Income	Aerospace & Defense - Segment Operating Income	$	10,706		$	12,494		Aerospace & Defense - Segment Operating Income	$	12,095		$	13,142
Industrial - Segment Operating Income	Industrial - Segment Operating Income	9,735			5,169			Industrial - Segment Operating Income	10,400			12,406
Corporate expenses	Corporate expenses	(8,002)			(6,588)			Corporate expenses	(7,850)			(9,664)
Subtotal	Subtotal	12,439			11,075			Subtotal	14,645			15,884
Restructuring charges, net	Restructuring charges, net	2,060			2,883			Restructuring charges, net	2,281			588
Special charges (recoveries), net	Special charges (recoveries), net	(2,869)			(45,175)			Special charges (recoveries), net	4,522			5,019
Special and restructuring charges (recoveries), net (1)	Special and restructuring charges (recoveries), net (1)	(809)			(42,292)			Special and restructuring charges (recoveries), net (1)	6,803			5,607

Restructuring related inventory charges (recoveries), net (1)	Restructuring related inventory charges (recoveries), net (1)	—			(602)			Restructuring related inventory charges (recoveries), net (1)	958			—

Acquisition amortization (2)	Acquisition amortization (2)	10,487			10,218			Acquisition amortization (2)	10,498			10,681
Acquisition depreciation (2)	Acquisition depreciation (2)	2,375			974			Acquisition depreciation (2)	1,326			980
Impairment charges	Impairment charges	—			116,182			Impairment charges	—			—
Restructuring, impairment, and other cost, net		12,862			126,772
Restructuring, impairment, and other costs, net								Restructuring, impairment, and other costs, net	12,782			11,661
Consolidated operating income (loss)	Consolidated operating income (loss)	386			(73,405)			Consolidated operating income (loss)	(4,940)			(1,384)
Interest expense, net	Interest expense, net	8,369			9,011			Interest expense, net	7,957			8,486
Other expense (income) , net		(1,503)			(2,680)
Other expense (income), net								Other expense (income), net	(1,173)			2,144
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	$	(6,480)		$	(79,736)		Loss from continuing operations before income taxes	$	(11,724)		$	(12,014)

Consolidated Operating Margin	Consolidated Operating Margin	0.2		%	(38.2)		%	Consolidated Operating Margin	(2.6)		%	(0.7)		%

(1) See Special and restructuring charges (recoveries), net in Note 5 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional details.	(1) See Special and restructuring charges (recoveries), net in Note 5 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional details.							(1) See Special and restructuring charges (recoveries), net in Note 5 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional details.
(2) Acquisition amortization and depreciation is recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.	(2) Acquisition amortization and depreciation is recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.							(2) Acquisition amortization and depreciation is recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.

Aerospace & Defense Segment


		Three Months Ended									Three Months Ended
(in thousands, except percentages)	(in thousands, except percentages)	April 4, 2021			March 29, 2020			Change		(in thousands, except percentages)	July 4, 2021			June 28, 2020			Change
Segment Orders	Segment Orders	$	72,999		$	72,031		$	968	Segment Orders	$	54,243		$	76,616		$	(22,373)
Net Revenues	Net Revenues	60,001			65,493			(5,492)		Net Revenues	$	60,761		$	62,241		$	(1,480)
Segment Operating Income	Segment Operating Income	10,706			12,494			(1,788)		Segment Operating Income	12,095			13,142			(1,047)
Segment Operating Margin	Segment Operating Margin	17.8		%	19.1		%			Segment Operating Margin	19.9		%	21.1		%

Aerospace & Defense segment orders ~~increased $1.0~~decreased $22.4 million, or ~~1.3%~~29%, for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020. The ~~increase~~decrease was driven by the timing of large orders in our Defense business of ~~24%~~49% partially offset by ~~declines~~increases in our Commercial business of ~~31%~~17% and favorable foreign currency fluctuations of 1%2%.

Aerospace & Defense segment net revenues decreased by ~~$5.5~~$1.5 million, or ~~8.4%~~2%, to ~~$60.0~~$60.8 million for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020. The decrease was driven by our Commercial business of ~~22%~~3% and Defense business of 1%3%, partially offset by favorable foreign currency fluctuations of 2%.

Segment operating income decreased ~~$1.8~~$1.0 million, or ~~14.3%~~8% for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020. The decrease in operating income was primarily driven by lower volume ~~in our Commercial business.~~and unfavorable mix.

Segment operating margin decreased from ~~19.1%~~21.1% in the three months ended ~~March 29,~~June 28, 2020 to ~~17.8%~~19.9% for the three months ended ~~April~~July 4, 2021. The reduced operating margin reflects the impact of lower volume and unfavorable mix.

Industrial Segment


		Three Months Ended							Three Months Ended
(in thousands, except percentages)	(in thousands, except percentages)	April 4, 2021			March 29, 2020		Change	(in thousands, except percentages)	July 4, 2021			June 28, 2020			Change
Segment Orders	Segment Orders	$	153,695		136,443		17,252	Segment Orders	$	155,959		$	116,023		$	39,936
Net Revenues as reported	Net Revenues as reported	120,654			126,720		(6,066)	Net Revenues as reported	$	129,585		$	123,825		$	5,760
Net Revenues excluding divestiture (1)		120,654			121,820		(1,166)

Segment Operating Income as reported	Segment Operating Income as reported	9,735			5,169		4,566	Segment Operating Income as reported	10,400			12,406			(2,006)
Segment Operating Income excluding divestiture (2)		9,735			5,169		4,566

Segment Operating Margin (adjusted)	Segment Operating Margin (adjusted)	8.1		%	4.2	%		Segment Operating Margin (adjusted)	8.0		%	10.0		%
(1) Adjusted for the January 2020 divestiture of the Instrumentation and Sampling ("I&S") business.. The I&S business generated revenues of $4.9 million for the three months ended March 29, 2020.
(2) Adjusted for the January 2020 divestiture of the I&S business. The I&S business contributed $0.0 million to segment operating income for the three months ended March 29, 2020.

Industrial segment orders increased ~~$17.3~~$39.9 million, or ~~12.6%~~34%, for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020, primarily driven by an increase in the Valves business of ~~34%~~39%, ~~largely~~primarily due to ~~the Refinery Valves business increasing 96%~~a large project order, an increase in Pumps of 19%, and favorable foreign currency fluctuations of ~~6%. These increases were offset by a decrease in Pumps of 1.0% and the impact of divestitures 3%~~7%.

Industrial segment net revenue ~~decreased $6.1~~increased $5.8 million, or ~~4.8%~~5% for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020. ~~Industrial segment net revenues, excluding divestitures,~~The increase was primarily driven by our Pumps business of 4% and favorable foreign currency fluctuations of 6%, partially offset by a decrease in our Valves business of 9%.

Segment operating income decreased ~~$1.2~~$2.0 million, or ~~1.0%, to $120.7 million,~~16% for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020. The decrease in margin was primarily driven by ~~declines~~our Valves business of 63% as a result of unfavorable product mix and volume in our ~~Pumps and~~Downstream end markets. The decrease in our operating income in our Valves ~~businesses of 3% and 11%, respectively,~~business was partially offset by ~~favorable foreign currency fluctuations of 5%. The decline in the Valves business is largely driven by a decrease~~an increase in our ~~Refinery Valves~~Pumps business of 19%.

Segment operating ~~income increased $4.6 million, or 88.3%~~margin (adjusted) decreased from 10.0% in the three months ended June 28, 2020 to 8.0% for the three months ended ~~April~~July 4, ~~2021 as compared to the three months ended March 29, 2020.~~2021. The ~~increase in margin was driven by an increase in our Pumps business~~decrease is largely due to ~~a one time charge of $5.9 million for allowance against a customer receivable in the three months ended March 29, 2020, partially offset by a decrease~~product mix and volume in our Valves business.

~~Segment operating margin (adjusted) increased from 4.2% in~~During the ~~three months ended March 29, 2020 to 8.1%~~second quarter of 2021 the Company was notified of a contract termination by one of its Industrial segment customers. The basis for this termination is under dispute and the ~~three months ended April 4, 2021.~~ultimate outcome of this matter is uncertain. The ~~increase is largely due to~~Company has a ~~one-time charge of $5.9 million for allowance against a customer~~net receivable in the ~~three months ended March 29, 2020.~~amount of $4.6 million as of July 4, 2021 relating to this contract. Further, the Company has outstanding guarantees of its performance under the contract in the aggregate amount of $3.4 million. Should the negotiation or settlement process be unfavorable for the Company, the Company is exposed to risk of loss for some or all of the net receivable under the contract, performance guarantees and potential future claims should any be asserted.

Corporate Expenses

Corporate expenses ~~increased $1.4~~decreased $1.8 million, or ~~21.5%~~19% for the three months ended ~~April~~July 4, 2021 as compared to the three months ended ~~March 29,~~June 28, 2020 primarily driven by a write-off of an aged accounts receivable during the ~~timing of information technology costs.~~period ended June 28, 2020.

Special and Restructuring Charges (Recoveries), net

During the three months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020, the Company recorded net ~~recoveries~~Restructuring and Special charges , net of ~~$0.8~~$6.8 million and ~~$42.3~~$5.6 million, respectively, within our condensed consolidated statements of operations caption "Special and restructuring charges (recoveries), net". These special and restructuring charges, net are described in further detail in Note 5 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Acquisition Amortization

During the three months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020, the Company recorded amortization expense of $10.5 million and ~~$10.2~~$10.7 million, respectively, for intangibles acquired in acquisitions completed subsequent to December 31, 2011. These amortization expenses are recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.

Acquisition Depreciation

During the three months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020, the Company recorded depreciation expense of ~~$2.4~~$1.3 million and $1.0 million, respectively, related to the step-up to fair value of the plant, property, and equipment from the acquisition of the fluid handling business of Colfax Corporation.

Interest Expense, net

During three months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020, the Company recorded interest expense of ~~$8.4~~$8.0 million and ~~$9.0~~$8.5 million, respectively. The ~~change~~reduction in interest expense was primarily due to lower outstanding debt ~~balances in addition to lower interest rates.~~balances.

Other Expense (Income), net

During the three months ended ~~April~~July 4, 2021, ~~we had~~the Company recorded other income, net of ~~$1.5~~$1.2 million, as compared to other ~~income,~~expense, net of ~~$2.7~~$2.1 million for the three months ended ~~March 29,~~June 28, 2020. The year-over-year ~~decrease~~increase is driven by ~~less~~ favorable foreign exchange ~~partially offset~~rate changes and by higher pension income. ~~Effective January 1, 2018 all non-service pension gains and losses are recorded in the Other Expense (Income), net caption on our condensed consolidated statement of operations.~~

Provision for / (Benefit from) Income Taxes

The table below outlines the change in effective tax rate for the three months ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020 (in thousands, except percentages).


		Three Months Ended							Three Months Ended
		April 4, 2021			March 29, 2020				July 4, 2021			June 28, 2020
Loss from Continuing Operations Before Income Taxes	Loss from Continuing Operations Before Income Taxes	$	(6,480)		$	(79,736)		Loss from Continuing Operations Before Income Taxes	$	(11,724)		$	(12,014)
Effective tax rate	Effective tax rate	(6.2)		%	(10.5)		%	Effective tax rate	(25.3)		%	181.2		%
Provision for/(benefit from) income taxes	Provision for/(benefit from) income taxes	$	400		$	8,374		Provision for/(benefit from) income taxes	$	2,961		$	(21,769)

The effective tax rate for the three months ended ~~April~~July 4, 2021, differed from the U.S. federal statutory rate of 21% primarily due to adjustments to the domestic and foreign valuation allowances and ~~adjustments~~an adjustment related to ~~uncertain tax positions.~~stock compensation. The effective tax rate for the three ~~months~~ ended ~~March 29,~~June, 28 2020, differed from the U.S. federal statutory rate primarily due to non-deductible expenses, goodwill impairment and dispositions. In 2020 the Company recorded a full valuation allowance in the USU.S. and Germany. The Company intends to continue maintaining valuation allowances on these deferred tax assets until there is sufficient evidence to support the release of all or some portion of these allowances.

Six Months Ended of 2021 Compared with Six Months Ended of 2020

Consolidated Operations


	Six Months Ended
(in thousands)	July 4, 2021		June 28, 2020		Total Change		Divestiture		Operations		Foreign Exchange
Net Revenues
Aerospace & Defense	$	120,762	$	127,734	$	(6,972)	$	—	$	(9,550)	$	2,578
Industrial	250,239		250,545		(306)		(4,900)		(9,191)		13,785
Consolidated Net Revenues	$	371,001	$	378,279	$	(7,278)	$	(4,900)	$	(18,741)	$	16,363

Net revenues for the six months ended July 4, 2021 were $371.0 million, a decrease of $7.3 million, or 2%, as compared to the six months ended June 28, 2020, primarily driven by operations of 5% and divestitures at 1% offset by favorable foreign exchange 4%.

Segment Results


	Six Months Ended
(in thousands, except percentages)	July 4, 2021			June 28, 2020
Net revenues
Aerospace & Defense	$	120,762		$	127,734
Industrial	250,239			250,545

Consolidated net revenues	$	371,001		$	378,279

Loss from continuing operations before income taxes
Aerospace & Defense - Segment Operating Income	$	22,800		$	25,636
Industrial - Segment Operating Income	20,135			17,575
Corporate expenses	(15,852)			(16,252)
Subtotal	27,083			26,959
Restructuring charges, net	4,341			3,471
Special charges (recoveries), net	1,654			(40,156)
Special and restructuring charges (recoveries), net (1)	5,995			(36,685)
Divestiture and inventory related restructuring charges and (recoveries), net	958			(602)

Impairment charges	—			116,182
Acquisition amortization (2)	20,984			20,898
Acquisition depreciation (2)	3,700			1,955
Acquisition amortization and other costs, net	25,642			138,433
Consolidated operating (loss) income	(4,554)			(74,789)
Interest expense, net	16,327			17,497
Other expense (income), net	(2,676)			(536)
Loss from continuing operations before income taxes	$	(18,205)		$	(91,750)

Consolidated Operating Margin	(1.2)		%	(19.8)		%

(1) See Special and restructuring charges (recoveries), net in Note 5 to the condensed consolidated financial statements for additional details.
(2) Acquisition amortization and depreciation is recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.

Aerospace & Defense Segment


	Six Months Ended
(in thousands, except percentages)	July 4, 2021			June 28, 2020			Change
Segment Orders	$	127,242		$	148,647		$	(21,405)
Net Revenues	$	120,762		$	127,734		$	(6,972)
Segment Operating Income	22,800			25,636			(2,836)
Segment Operating Margin	18.9		%	20.1		%

Aerospace & Defense segment orders decreased $21.4 million, or 14%, for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020, primarily driven by decreases in our Defense business of 18% and Commercial business of 12% partially offset by favorable foreign exchange of 2%.

Aerospace & Defense segment net revenues decreased by $7 million, or 5%, to $120.8 million for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020. The decrease was driven by a decrease in our Commercial business of 15%, and Defense business of 2% partially offset with favorable exchange of 2%.

Aerospace & Defense segment operating income decreased $2.8 million, or 11%, to $22.8 million for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020. The decrease in operating income was primarily driven by lower volume and unfavorable mix.

Aerospace & Defense segment operating margin decreased from 20.1% in the six months ended June 28, 2020 to 18.9% for the six months ended July 4, 2021. The reduced operating margin reflects the impact of lower volume and unfavorable mix.

Industrial Segment


	Six Months Ended
(in thousands, except percentages)	July 4, 2021			June 28, 2020			Change
Segment Orders	$	309,654		$	252,466		$	57,188
Net Revenues as reported	$	250,239		$	250,545		$	(306)
Net Revenues excluding divestiture (1)	250,239			245,645			4,594
Segment Operating Income as reported	20,135			17,575			2,560
Segment Operating Income excluding divestiture (2)	20,135			17,575			2,560
Segment Operating Margin (adjusted)	8.0		%	7.2		%
(1) Adjusted for the January 2020 divestiture of the Instrumentation and Sampling ("I&S") business The I&S business generated revenues of $4.9 million for the six months ended June 28,2020
(2) Adjusted for the January 2020 divestiture of the I&S business. The I&S business contributed $0.0 to segment operating income for the six months ended June 28, 2020.

Industrial segment orders increased $57.2 million, or 23%, for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020, driven primarily by the Valves business of 37%, Pumps business of 8% and favorable foreign exchange of 6%.

Industrial segment net revenue decreased $0.3 million, or 0%, for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020. Industrial segment net revenue, excluding divestiture, increased $4.6 million, or 2%, to $250.2 million for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020. The decrease in segment net revenue was primarily driven by declines within our Valves business of 10%, mostly offset by favorable foreign exchange of 6%.

Industrial segment operating income increased $2.6 million, or 15%, for the six months ended July 4, 2021 as compared to the six months ended June 28, 2020. The increase was primarily driven by the impact of a non-repeating receivable write off in the Pumps business in the period ended March 29, 2020 and operating improvements, partially offset by the impact of unfavorable product mix and volume in our Valves business.

Industrial segment operating margin (adjusted) increased to 8.0% in the six months ended July 4, 2021 from 7.2% for the six months ended June 28, 2020.The improved margin was primarily driven by the Pumps business.

Corporate Expenses

Corporate expenses were $15.9 for the six months ended July 4, 2021 compared to $16.3 for the six months ended June 28, 2020 primarily driven by non-repeating aged receivable write off in the six months ended June 28, 2020 partially offset by higher outside services costs from IT initiatives.

Special and Restructuring Charges (Recoveries), net

During the six months ended July 4, 2021 and June 28, 2020, the Company recorded net charges of $6.0 million and net recoveries of $(36.7) million, within our condensed consolidated statements of operations caption "Special and restructuring (recoveries) charges, net". These special and restructuring (recoveries) charges, net are described in further detail in Note 5 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Divestiture and Inventory related Restructuring charges and (recoveries), net

During the six months ended July 4, 2021 and June 28, 2020, the Company recorded net charges (recoveries) of $0.9 million and ($0.6) million, respectively, within our condensed consolidated statements of operations caption “Cost of revenues”. This adjustment includes the gross profit or loss for businesses that are divested in the quarter, as well as certain restructuring costs and recoveries related to inventory that are recorded in cost of revenues instead of special and restructuring charges. These types of inventory restructuring costs typically relate to the discontinuance of a product line or manufacturing inefficiencies directly related to a restructuring action.

Acquisition Amortization

During the six months ended July 4, 2021 and June 28, 2020, the Company recorded amortization expense of $21.0 million and $20.9 million, respectively, for intangibles acquired in acquisitions completed subsequent to December 31, 2011. These amortization expenses are recorded in either cost of revenues or selling, general, and administrative expenses depending upon the nature of the underlying asset.

Acquisition Depreciation

During the six months ended July 4, 2021 and June 28, 2020, the Company recorded depreciation expense of $3.7 million and $2.0 million, respectively, related to the step-up to fair value of the plant, property, and equipment from the acquisition of the fluid handling business of Colfax Corporation.

Interest Expense, net

Net interest expense decreased $1.2 million to $16.3 million during the six months ended July 4, 2021 compared to the six months ended June 28, 2020. The change in interest expense was due to both lower debt balances and lower interest rates.

Other Expense (Income), net

During the six months ended July 4, 2021, the Company recorded other income, net of $2.7 million, as compared to other income, net of $0.5 million for the six months ended June 28, 2020. The change in other income was driven by favorable foreign exchange rate movements and increased pension income.

Provision for / (Benefit from) Income Taxes

The table below outlines the change in effective tax rate for the six months ended July 4, 2021 and June 28, 2020 (in thousands, except percentages):


	Six Months Ended
	July 4, 2021			June 28, 2020
Loss from Continuing Operations Before Income Taxes	$	(18,205)		$	(91,750)
Effective tax rate	(18.5)		%	14.6		%
Provision for/(benefit from) income taxes	$	3,360		$	(13,395)

The effective tax rate for the six months ended July 4, 2021, differed from the U.S. federal statutory rate of 21% primarily due to adjustments to the domestic and foreign valuation allowances and an adjustment related to stock compensation. The effective tax rate for the six months ended June 28, 2020, differed from the U.S. federal statutory rate primarily due to non-deductible expenses, goodwill impairment and dispositions. In 2020 the Company recorded a full valuation allowance in the U.S. and Germany. The Company intends to continue maintaining valuation allowances on these deferred tax assets until there is sufficient evidence to support the release of all or some portion of these allowances.

Off-Balance Sheet Arrangements and Contractual Obligations

We have no off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors. There have been no material changes outside of the ordinary course of business in contractual obligations set forth in the table included within our most recent Annual Report on Form 10-K.

Liquidity and Capital Resources

Our liquidity needs arise primarily from capital investment in machinery, equipment and the improvement of facilities, funding working capital requirements to support business growth initiatives, acquisitions, and debt service costs. We have historically generated cash from operations and have adequate liquidity, with resources available for reinvesting in existing businesses and managing our capital structure on a short and long-term basis.

The following table summarizes our cash flow activities for the ~~three months~~six month periods indicated (in thousands):


		April 4, 2021		March 29, 2020			July 4, 2021		June 28, 2020
Cash flow provided by (used in):	Cash flow provided by (used in):					Cash flow provided by (used in):
Operating activities	Operating activities	$	(17,703)	$	(23,947)	Operating activities	$	(6,719)	$	(48,830)
Investing activities	Investing activities	4,613		167,028		Investing activities	4,955		153,686
Financing activities	Financing activities	13,877		(51,448)		Financing activities	(868)		(61,698)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,545)		(5,389)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,627)		(2,421)
Increase / (decrease) in cash, cash equivalents and restricted cash	Increase / (decrease) in cash, cash equivalents and restricted cash	$	(758)	$	86,244	Increase / (decrease) in cash, cash equivalents and restricted cash	$	(4,259)	$	40,737

During the ~~three~~six months ended ~~April~~July 4, 2021, cash used in operations was ~~$17.7~~$6.7 million compared to cash used in operations of ~~$23.9~~$48.8 million during the prior corresponding period. The ~~$6.2~~$42.1 million reduction in cash used in operating activities was ~~primarily~~ driven by increased cash flow from working capital and a reduction ofin net cash used in discontinued ~~operations.~~operating activities. The improved cash flow from working capital was primarily driven by accounts payable which was favorably impacted by improved end markets and operating environments compared to the first half of 2020.

During the ~~three~~six months ended ~~April~~July 4, 2021, wethe Company generated ~~$4.6~~$5.0 million of cash from investing activities as compared to ~~$167.0~~$153.7 million from investing activities during the prior corresponding period. The ~~$162.4~~$148.7 million period over period decrease in cash generated was primarily driven by the cash received in the three months ended March 29, 2020 from the sale of the Company's I&S business.

During the ~~three~~six months ended ~~April~~July 4, 2021, ~~we generated $13.9~~the Company used $0.9 million of cash from financing activities as compared to ~~$51.4~~$61.7 million of cash used in financing activities during the same period in 2020. The ~~$65.3~~$60.8 million period over period decrease in cash used in financing activities ~~arises from~~is a result of lower net debt repayments in the current ~~period, during~~period. During the ~~three~~six months ended ~~March 29,~~June 28, 2020 the Company paid down ~~$161.8~~$191.1 million on its term loan from proceeds received from the sale of the I&S ~~business..~~business.

As of ~~April~~July 4, 2021, total debt was ~~$525.6~~$512.4 million compared to $507.9 million as of December 31, 2020. Total debt is net of unamortized term loan debt issuance costs of ~~$11.3~~$10.6 million and $12.0 million at ~~April~~July 4, 2021 and December 31, 2020, respectively. Total debt as a percentage of total shareholders’ equity was ~~268%~~280% as of ~~April~~July 4, 2021 compared to 246% as of December 31, 2020. As of ~~April~~July 4, 2021, we had gross borrowings of ~~$536.9~~$523.0 million outstanding under the 2017 Credit Agreement and ~~$27.3~~$31.4 million outstanding on letters of credit, with available capacity to borrow an additional ~~$85.5~~$94.0 million under the revolving credit facility, subject to the terms and conditions of that facility.

The 2017 Credit Agreement provides for a $150.0 million revolving line of credit with a five year maturity and a $785.0 million term loan with a seven year maturity. The Credit Agreement revolving line of credit facility matures on December 11, 2022 whereas the term loan facility matures on December 11, 2024. We entered into the 2017 Credit Agreement to fund acquisitions, to support our operational growth initiatives and working capital needs, and for general corporate purposes. On February 26, 2020, the Company amended its term loan to lower the interest rate associated with the applicable margin calculation from LIBOR plus an applicable margin of 3.5% to LIBOR plus an applicable margin of 3.25%.

The 2017 Credit Agreement contains covenants that require, among other items, maintenance of certain financial ratios and also limits our ability to: enter into secured and unsecured borrowing arrangements; issue dividends to shareholders; acquire and dispose of businesses; invest in capital equipment; transfer assets among domestic and international entities; participate in certain higher yielding long-term investment vehicles; and issue additional shares of our stock which limits our ability to borrow under the credit facility. The primary financial covenant is first lien net leverage, a ratio of total secured debt (less cash and cash equivalents) to total adjusted earnings before interest expense, taxes, depreciation, and amortization based on the 12 months ended at the testing period. We were in compliance with all financial covenants related to our existing debt obligations at ~~April~~July 4, 2021 and we believe it is likely that we will continue to meet such covenants for at least the next twelve months from date of issuance of the financial statements.

~~Our ratio of current assets to current liabilities was 2.5:1 as of April 4, 2021, which was comparable with our ratio of 2.4:1 as of December 31, 2020.~~

As of ~~April~~July 4, 2021, cash and cash equivalent balances, totaled ~~$75.7~~$72.2 million. Substantially, all of the Company's cash and cash equivalent balances are held in foreign bank accounts. This compares to $76.5 million of cash and cash equivalents as of December 31, 2020, substantially all of which was held in foreign bank accounts. The cash and cash equivalents located at our foreign subsidiaries may not be repatriated to the U.S. or other jurisdictions without certain tax implications. If we should require more capital in the U.S. than is generated by our domestic operations, we could elect to repatriate future earnings from foreign jurisdictions or we may utilize our 2017 Credit Agreement. These alternatives could result in a higher effective tax rate or increase to our interest expense.

Based on our existing cash reserves, expected cash flows from operations and contractually available borrowings under our credit facility, we expect to have sufficient liquidity to fund working capital needs and future growth over at least the next twelve months from date of filing the quarterly financial statements.

3235


ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market Risk

The Company is exposed to certain risks relating to its ongoing business operations including foreign currency exchange rate risk, interest rate risk, and commodity raw material prices which may be impacted by tariffs on foreign-sourced materials.

Foreign Currency Exchange Risk

The Company’s foreign currency exchange rate risk is principally from the Euro, British Pound, and Swedish Krona. The effect of transaction gains and losses is reported within Other expense (income), net in the Condensed Consolidated Statements of Operations.

The Company has entered into a cross-currency swap agreement to hedge against future volatility in exchange rates. See Financial Instruments in Note 9, Financing Arrangements, of the condensed consolidated financial statements included in this Quarterly Report Form 10-Q.

Interest Rate Risk

Loans under our credit facility bear interest at variable rates which reset every 30 to 180 days depending on the rate and period selected by the Company. The Company entered into a hedging agreement to mitigate the inherent interest rate risk associated with our outstanding debt. Refer to Financial Instruments in Note 9, Financing Arrangements, of the condensed consolidated financial statements included in this Quarterly Report Form 10-Q.

3336


ITEM 4.			CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information we disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") (our principal executive officer and principal financial officer, respectively), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our CEO and CFO concluded that, as of ~~April~~July 4, 2021, the Company's disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended ~~April~~July 4, 2021, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3437

PART II. OTHER INFORMATION


ITEM 1.			LEGAL PROCEEDINGS

For information regarding our legal proceedings refer to the first two paragraphs of Note 11 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, which disclosure is referenced herein.


ITEM 1A.			RISK FACTORS

Not applicable.


ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Not applicable.


ITEM 3.			DEFAULTS UPON SENIOR SECURITIES

Not applicable.


ITEM 4.			MINE SAFETY DISCLOSURES

Not applicable.


ITEM 5.			OTHER INFORMATION

~~Disclosure Pursuant to Item 5.03 of Form 8-K: Amendments to Bylaws~~Not applicable.

On May 10, 2021, our board of directors (the “Board”) approved an amendment and restatement of our Second Amended and Restated By-Laws (as so amended and restated, the “Third Amended and Restated By-Laws”). The Third Amended and Restated By-Laws, which were effective upon adoption by the Board, include the following changes:

•~~Adding provisions that expressly permit us to hold stockholder meetings by means of remote communication (Sections 1, 5 and 9 of Article I);~~

•Updating the advance notice provisions to, among other things, add certain disclosure requirements relating to proposals and director nominations submitted by stockholders (Sections 3 and 5 of Article I);

•Updating procedures relating to Board and stockholder meetings, including the recess and adjournment thereof, the conduct thereof and the parties who may preside thereat (Sections 5, 10, 11 and 12 of Article I; Section 10 of Article III);

•Adding provisions addressing the means by which a meeting of the Board or a committee thereof may be called, and action taken thereat, in the event of an emergency, in accordance with recent updates to the Delaware General Corporation Law (Section 16 of Article II);

•Adding a provision designating the Court of Chancery of the State of Delaware (or, if such court does not have jurisdiction, the federal district court for the District of Delaware) the sole and exclusive forum for any derivative action brought on our behalf; any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers, employees or stockholders to us or our stockholders; any action asserting a claim arising under the Delaware General Corporation Law or as to which the Delaware General Corporation Law confers jurisdiction on the Court of Chancery of the State of Delaware; or any action asserting a claim arising under our Certificate of Incorporation or our Third Amended and Restated By-laws or governed by the internal affairs doctrine, unless we consent in writing to the selection of an alternative forum (Section 8 of Article VI); and

•Adding a provision designating the federal district courts the sole and exclusive forum for the resolution of any claims arising under the Securities Act of 1933, unless we consent in writing to the selection of an alternative forum (Section 8 of Article VI).

The Third Amended and Restated By-Laws also include certain technical, conforming and clarifying changes. The foregoing description of the Third Amended and Restated By-Laws is qualified in its entirety by reference to the full text of the Third Amended and Restated By-Laws, a copy of which is attached hereto as Exhibit 3.1 and incorporated by reference herein.

~~Disclosure Pursuant to Item 5.02 of Form 8-K: Departure of Sumit Mehrotra, President, Industrial~~

~~Sumit Mehrotra, President, Industrial Group submitted his resignation to the Company on May 10, 2021. Mr. Mehrotra will continue in his role through the second quarter of 2021.~~

3638


ITEM 6.			EXHIBITS


Exhibit No.		Description and Location
3.1*		Amended and Restated Certificate of Incorporation of the Company, ~~as amended~~incorporated herein by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10Q, filed with the SEC on May 12, 2021.
3.2*		Third Amended and Restated By-laws of the Company, incorporated herein by reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10Q, filed with the SEC on May 12, 2021.
10.1*		~~Form of Updated Restricted Stock Unit Agreement for Employees under the~~ 2019 Stock Option and Incentive Plan,
~~10.2~~*		~~Form of Updated Restricted Stock Unit Agreement for Directors under~~ as amended, incorporated hereby by reference to Exhibit B to the ~~2019 Stock Option and Incentive Plan~~
~~10.3~~*		~~Form of Updated Performance-Based Restricted Stock Unit Agreement for Employees under~~Company's Definitive Proxy Statement, filed with the ~~2019 Stock Option and Incentive Plan~~
~~10.4~~*		~~Form of MSP Restricted Stock Unit Agreement for Employees under the 2019 Stock Option and Incentive Plan.~~SEC on April 13, 2021.
31.1*		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101		The following financial statements (Unaudited) from CIRCOR International, Inc.'s Quarterly Report on Form 10-Q for the quarter ended ~~September 27, 2020,~~July 4, 2021, as filed with the Securities and Exchange Commission on ~~May 12,~~August 10, 2021, formatted in XBRL (eXtensible Business Reporting Language), as follows:
	(i)	Condensed Consolidated Balance Sheets as of ~~April~~July 4, 2021 and December 31, 2020
	(ii)	Condensed Consolidated Statements of Operations for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020
	(iii)	Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020
	(iv)	Condensed Consolidated Statements of Cash Flows for the ~~Three~~Six Months ~~Ended April~~ended July 4, 2021 and ~~March 29,~~June 28, 2020
	(v)	Condensed Consolidated Statements of Shareholders' Equity for the Three and Six Months Ended ~~April~~July 4, 2021 and ~~March 29,~~June 28, 2020
	(vi)	Notes to Condensed Consolidated Financial Statements
104		Cover Page Interactive Date File (formatted as inline XBRL and contained in Exhibit 101)
*	Filed with this report.
**	Furnished with this report.

3739

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



			CIRCOR INTERNATIONAL, INC.

~~May 12,~~August 10, 2021			/s/ Scott A. Buckhout
			Scott A. Buckhout
			President and Chief Executive Officer
			Principal Executive Officer

~~May 12,~~August 10, 2021			/s/ Abhi Khandelwal
			Abhi Khandelwal
			Senior Vice President and Chief Financial Officer
			Principal Financial Officer

~~May 12,~~August 10, 2021			/s/ Amit Goel
			Amit Goel
			Vice President and Chief Accounting Officer
			Principal Accounting Officer

3840